| Title |
Publication Date |
Price |
ABIOMED Inc -Financial Company Report
|
February 2008 |
£110 |
Bukwang Pharmaceutical Company Limited -Company Report
|
February 2008 |
£240 |
BurnsAdler Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
C&O Pharmaceutical Technology (Holdings) Limited -Company Report
|
February 2008 |
£240 |
British Biologicals -Company Report
|
February 2008 |
£240 |
Britannia Pharmaceuticals Limited -Company Report
|
February 2008 |
£240 |
Bravo Healthcare Ltd. -Company Report
|
February 2008 |
£240 |
Breckenridge Pharmaceutical, Inc. -Company Report
|
February 2008 |
£240 |
CBio Limited -Company Report
|
February 2008 |
£240 |
CCL Pharmaceuticals -Company Report
|
February 2008 |
£240 |
COOPER PHARMA -Company Report
|
February 2008 |
£240 |
CORIA Laboratories, Ltd. -Company Report
|
February 2008 |
£240 |
CSC Pharmaceuticals Handels GmbH -Company Report
|
February 2008 |
£240 |
CLL PHARMA -Company Report
|
February 2008 |
£240 |
CJ Corp. -Company Report
|
February 2008 |
£240 |
CEPTYR, Inc. -Company Report
|
February 2008 |
£240 |
CHO -A Pharmaceutical Company -Company Report
|
February 2008 |
£240 |
Braintree Laboratories Inc. -Company Report
|
February 2008 |
£240 |
Bosnalijek d.d. -Company Report
|
February 2008 |
£240 |
Biotron Limited -Company Report
|
February 2008 |
£240 |
Biovertis AG -Company Report
|
February 2008 |
£240 |
Biovitrum AB -Company Report
|
February 2008 |
£240 |
Biotie Therapies Corp. -Company Report
|
February 2008 |
£240 |
Biotica Technology Limited -Company Report
|
February 2008 |
£240 |
Biotest AG -Company Report
|
February 2008 |
£240 |
Biothera. -Company Report
|
February 2008 |
£240 |
Biotherapix SLU -Company Report
|
February 2008 |
£240 |
Blaine Pharmaceuticals -Company Report
|
February 2008 |
£240 |
Blairex Laboratories, Inc. -Company Report
|
February 2008 |
£240 |
Bone Medical Ltd -Company Report
|
February 2008 |
£240 |
Boram Pharm. Co., Ltd. -Company Report
|
February 2008 |
£240 |
Boryung Pharmaceutical Company, Ltd. -Company Report
|
February 2008 |
£240 |
Bolder BioTechnology, Inc. -Company Report
|
February 2008 |
£240 |
Boehringer Ingelheim GmbH -Company Report
|
February 2008 |
£240 |
Blansett Pharmacal Co., Inc. -Company Report
|
February 2008 |
£240 |
Blue Cross Laboratories, Ltd. -Company Report
|
February 2008 |
£240 |
CSL Behring (formerly ZLB Behring) -Company Report
|
February 2008 |
£240 |
CSL Limited -Company Report
|
February 2008 |
£240 |
China Medical System Holdings Limited -Company Report
|
February 2008 |
£240 |
China National Biotec Group -Company Report
|
February 2008 |
£240 |
Chipscreen Biosciences Ltd -Company Report
|
February 2008 |
£240 |
Chiesi Farmaceutici S.p.A -Company Report
|
February 2008 |
£240 |
Chenho Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Changzhou Siyao Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
ChemoCentryx, Inc. -Company Report
|
February 2008 |
£240 |
Chong Kun Dang Pharmaceutical Corp. (CKD Pharm) -Company Report
|
February 2008 |
£240 |
Chongqing -Yaoyou -Pharmaceutical -Company Report
|
February 2008 |
£240 |
Cipla Ltd. -Company Report
|
February 2008 |
£240 |
Circ Pharma Limited -Company Report
|
February 2008 |
£240 |
Cirin Pharmaceuticals (Private) Limited -Company Report
|
February 2008 |
£240 |
Chugai Pharma USA, LLC. -Company Report
|
February 2008 |
£240 |
Chroma Therapeutics Ltd -Company Report
|
February 2008 |
£240 |
Chongqing Tonghe Pharmaceutical CO., LTD -Company Report
|
February 2008 |
£240 |
Choongwae Pharma Corporation -Company Report
|
February 2008 |
£240 |
Changchun ChangSheng Gene Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Ceregene, Inc -Company Report
|
February 2008 |
£240 |
Canderm Pharma Inc. -Company Report
|
February 2008 |
£240 |
Cangene Corporation -Company Report
|
February 2008 |
£240 |
Capellon Pharmaceuticals, Ltd. -Company Report
|
February 2008 |
£240 |
Can -Fite BioPharma, Ltd. -Company Report
|
February 2008 |
£240 |
Camurus AB -Company Report
|
February 2008 |
£240 |
Cambria Biosciences -Company Report
|
February 2008 |
£240 |
Cambridge Laboratories -Company Report
|
February 2008 |
£240 |
Capricorn Pharma, Inc. -Company Report
|
February 2008 |
£240 |
Cara Therapeutics Inc -Company Report
|
February 2008 |
£240 |
Celtic Pharma -Company Report
|
February 2008 |
£240 |
Centocor, Inc. -Company Report
|
February 2008 |
£240 |
Centrix Pharmaceutical, Inc. -Company Report
|
February 2008 |
£240 |
Celon Pharma -Company Report
|
February 2008 |
£240 |
Cellerant Therapeutics, Inc. -Company Report
|
February 2008 |
£240 |
CellGate, Inc -Company Report
|
February 2008 |
£240 |
Celldex Therapeutics, Inc -Company Report
|
February 2008 |
£240 |
Biotec Pharmacon ASA -Company Report
|
February 2008 |
£240 |
Biota Holdings Limited -Company Report
|
February 2008 |
£240 |
Zynex Medical Holdings Inc -Financial Company Report
|
February 2008 |
£110 |
aRigen Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
apex laboratories limited -Company Report
|
February 2008 |
£240 |
ZymoGenetics Inc -Financial Company Report
|
February 2008 |
£110 |
ZymeTx Inc -Financial Company Report
|
February 2008 |
£110 |
Zila Inc -Financial Company Report
|
February 2008 |
£110 |
Zimmer Holdings Inc -Financial Company Report
|
February 2008 |
£110 |
Zoll Medical Corporation -Financial Company Report
|
February 2008 |
£110 |
axxonis Pharma AG. (formerly NeuroBiotec Pharma AG) -Company Report
|
February 2008 |
£240 |
bene -Arzneimittel GmbH -Company Report
|
February 2008 |
£240 |
BIOFARM Sp. z o.o. -Company Report
|
February 2008 |
£240 |
BIOMAX Co. Ltd -Company Report
|
February 2008 |
£240 |
BIOMED Wytwornia Surowic i Szczepionek Sp. z o.o. -Company Report
|
February 2008 |
£240 |
BIOCODEX -Company Report
|
February 2008 |
£240 |
BINEX Co., Ltd -Company Report
|
February 2008 |
£240 |
inVentiv Health Inc -Financial Company Report
|
February 2008 |
£110 |
BETA DERMACEUTICALS, INC. -Company Report
|
February 2008 |
£240 |
Zaxis International Inc. -Financial Company Report
|
February 2008 |
£110 |
ZIOPHARM Oncology Inc -Financial Company Report
|
February 2008 |
£110 |
WuXi PharmaTech (Cayman) Inc. -Financial Company Report
|
February 2008 |
£110 |
Wyeth -Financial Company Report
|
February 2008 |
£110 |
XINO Corp -Financial Company Report
|
February 2008 |
£110 |
Wright Medical Group Inc -Financial Company Report
|
February 2008 |
£110 |
World Heart Corporation -Financial Company Report
|
February 2008 |
£110 |
West Pharmaceuticals Services Inc -Financial Company Report
|
February 2008 |
£110 |
Women First Healthcare Inc. -Financial Company Report
|
February 2008 |
£110 |
XOMA Ltd -Financial Company Report
|
February 2008 |
£110 |
XTENT, Inc. -Financial Company Report
|
February 2008 |
£110 |
Xethanol Corp -Financial Company Report
|
February 2008 |
£110 |
YM BioSciences Inc -Financial Company Report
|
February 2008 |
£110 |
Young Innovations Inc -Financial Company Report
|
February 2008 |
£110 |
Xenoport Inc -Financial Company Report
|
February 2008 |
£110 |
Xenomics Inc -Financial Company Report
|
February 2008 |
£110 |
XTL Biopharmaceuticals Ltd -Financial Company Report
|
February 2008 |
£110 |
Xechem International Inc. -Financial Company Report
|
February 2008 |
£110 |
BOUTY -Company Report
|
February 2008 |
£240 |
BTG plc -Company Report
|
February 2008 |
£240 |
Biocompatibles International plc -Company Report
|
February 2008 |
£240 |
Biofarma Pharmaceutical Industry Co. Inc. -Company Report
|
February 2008 |
£240 |
Biofrontera AG -Company Report
|
February 2008 |
£240 |
Biochem Pharmaceutical Industries -Company Report
|
February 2008 |
£240 |
Biocad -Company Report
|
February 2008 |
£240 |
BioWa, Inc. -Company Report
|
February 2008 |
£240 |
BioXell S.p.A. -Company Report
|
February 2008 |
£240 |
Biokine Therapeutics Ltd. -Company Report
|
February 2008 |
£240 |
Biolex Therapeutics -Company Report
|
February 2008 |
£240 |
Bionomics Limited -Company Report
|
February 2008 |
£240 |
Biopole S.A. -Company Report
|
February 2008 |
£240 |
BiopolyMed Inc. -Company Report
|
February 2008 |
£240 |
Bionaut Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Biomedica foscama -Company Report
|
February 2008 |
£240 |
Biological E. Ltd. -Company Report
|
February 2008 |
£240 |
Biomedica International -Company Report
|
February 2008 |
£240 |
BioVex Inc -Company Report
|
February 2008 |
£240 |
BioPhausia AB -Company Report
|
February 2008 |
£240 |
BiPar Sciences, Inc. -Company Report
|
February 2008 |
£240 |
Bilim Pharmaceuticals -Company Report
|
February 2008 |
£240 |
Bio -Pharm, Inc. -Company Report
|
February 2008 |
£240 |
Bharat Serums And Vaccines Limited -Company Report
|
February 2008 |
£240 |
Bharat Biotech International Limited -Company Report
|
February 2008 |
£240 |
BestoChem Formulations (I) Ltd -Company Report
|
February 2008 |
£240 |
Beximco Pharmaceuticals Ltd. -Company Report
|
February 2008 |
£240 |
Bio3 Research -Company Report
|
February 2008 |
£240 |
BioAlliance Pharma -Company Report
|
February 2008 |
£240 |
BioLineRx, Ltd. -Company Report
|
February 2008 |
£240 |
BioNumerik Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
BioPartners GmbH -Company Report
|
February 2008 |
£240 |
BioInvent International AB -Company Report
|
February 2008 |
£240 |
BioCore Medical Technologies, Inc. -Company Report
|
February 2008 |
£240 |
BioAxone Therapeutic Inc. -Company Report
|
February 2008 |
£240 |
BioCancell Therapeutics, Inc. -Company Report
|
February 2008 |
£240 |
Claris Lifesciences Limited -Company Report
|
February 2008 |
£240 |
Clavis Pharma ASA -Company Report
|
February 2008 |
£240 |
Elite Pharma Pvt. Ltd. -Company Report
|
February 2008 |
£240 |
Elixir Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Embil Pharmaceutical Co. Ltd. -Company Report
|
February 2008 |
£240 |
Elder Pharmaceuticals Ltd -Company Report
|
February 2008 |
£240 |
Egyptian Co. for Chemicals & Pharmaceuticals S.A.E. (ADWIA) -Company Report
|
February 2008 |
£240 |
EVIT Labs, Inc. -Company Report
|
February 2008 |
£240 |
East India Pharmaceutical Works Limited -Company Report
|
February 2008 |
£240 |
Efroze Chemical Industries -Company Report
|
February 2008 |
£240 |
Emcure Pharmaceuticals Ltd. -Company Report
|
February 2008 |
£240 |
EnVivo Pharmaceuticals -Company Report
|
February 2008 |
£240 |
EpiGenesis Pharmaceuticals Inc -Company Report
|
February 2008 |
£240 |
Epla Laboratories (Pvt.) Ltd. -Company Report
|
February 2008 |
£240 |
Erimos Pharmaceuticals -Company Report
|
February 2008 |
£240 |
Epeius Biotechnologies Corp -Company Report
|
February 2008 |
£240 |
Entegrion, Inc. -Company Report
|
February 2008 |
£240 |
Enaleni Pharmaceuticals Ltd -Company Report
|
February 2008 |
£240 |
Endocyte, Inc. -Company Report
|
February 2008 |
£240 |
EUSA Pharma Inc. -Company Report
|
February 2008 |
£240 |
ESPEFA -Company Report
|
February 2008 |
£240 |
DynPort Vaccine Company LLC -Company Report
|
February 2008 |
£240 |
Dynapharm (M) Sdn. Bhd. -Company Report
|
February 2008 |
£240 |
Dynogen Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
DrugAbuse Sciences, Inc. -Company Report
|
February 2008 |
£240 |
Drug Houses of Australia (Asia) Pte. Ltd. -Company Report
|
February 2008 |
£240 |
Drogsan Pharmaceuticals -Company Report
|
February 2008 |
£240 |
Drossapharm Ltd -Company Report
|
February 2008 |
£240 |
EBEWE Pharma Ges.m.b.H. Nfg.KG -Company Report
|
February 2008 |
£240 |
ECR Pharmaceuticals -Company Report
|
February 2008 |
£240 |
ENT Technologies PTY LTD -Company Report
|
February 2008 |
£240 |
ENTOD PHARMACEUTICALS LTD. -Company Report
|
February 2008 |
£240 |
ERYtech Pharma -Company Report
|
February 2008 |
£240 |
ENKAM Pharmaceutical A/S -Company Report
|
February 2008 |
£240 |
ELSaad Pharmaceutical Industries -Company Report
|
February 2008 |
£240 |
EGIS Pharmaceuticals PLC -Company Report
|
February 2008 |
£240 |
ELPEN Pharmaceutical Co. Inc. -Company Report
|
February 2008 |
£240 |
Errant Gene Therapeutics, LLC -Company Report
|
February 2008 |
£240 |
Eskayef Bangladesh Limited -Company Report
|
February 2008 |
£240 |
FDC Ltd. -Company Report
|
February 2008 |
£240 |
FIT Biotech Oyj Plc. -Company Report
|
February 2008 |
£240 |
FRANCO -INDIAN PHARMACEUTICALS PVT. LTD. -Company Report
|
February 2008 |
£240 |
elbion NV -Company Report
|
February 2008 |
£240 |
e -Therapeutics -Company Report
|
February 2008 |
£240 |
biosyn Corporation -Company Report
|
February 2008 |
£240 |
curasan AG -Company Report
|
February 2008 |
£240 |
FSP GALENA -Company Report
|
February 2008 |
£240 |
Faust Pharmaceuticals -Company Report
|
February 2008 |
£240 |
FibroGen, Inc. -Company Report
|
February 2008 |
£240 |
Fidia farmaceutici S.p.A. -Company Report
|
February 2008 |
£240 |
FivePrime Therapeutics, Inc. -Company Report
|
February 2008 |
£240 |
Fertin Pharma A/S -Company Report
|
February 2008 |
£240 |
Ferring Pharmaceuticals A/S -Company Report
|
February 2008 |
£240 |
Ferndale Laboratories, Inc. -Company Report
|
February 2008 |
£240 |
Ferozsons Laboratories Limited -Company Report
|
February 2008 |
£240 |
Faron Pharmaceuticals Ltd. -Company Report
|
February 2008 |
£240 |
Farmoquimica S/A -Company Report
|
February 2008 |
£240 |
Eurodrug Laboratories -Company Report
|
February 2008 |
£240 |
Everett Laboratories, Inc. -Company Report
|
February 2008 |
£240 |
Evolutec Group plc -Company Report
|
February 2008 |
£240 |
Euphoric Pharmaceuticals (P) Ltd -Company Report
|
February 2008 |
£240 |
Ethypharm SA -Company Report
|
February 2008 |
£240 |
Essex Bio -Technology Limited -Company Report
|
February 2008 |
£240 |
Esteve -Company Report
|
February 2008 |
£240 |
Evotec AG -Company Report
|
February 2008 |
£240 |
ExonHit Therapeutics SA -Company Report
|
February 2008 |
£240 |
Fabre -Kramer Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Falcon Pharmaceuticals, Ltd. -Company Report
|
February 2008 |
£240 |
Farmacija d.o.o. -Company Report
|
February 2008 |
£240 |
FASgen, Inc. -Company Report
|
February 2008 |
£240 |
FARAN LABORATORIES sa -Company Report
|
February 2008 |
£240 |
Expression Genetics, Inc. -Company Report
|
February 2008 |
£240 |
FAES FARMA -Company Report
|
February 2008 |
£240 |
Dr. Kade Pharmazeutische Fabrik GmbH -Company Report
|
February 2008 |
£240 |
Dr. Falk Pharma GmbH -Company Report
|
February 2008 |
£240 |
Cygnus Healthcare Specialities Pvt. Ltd. -Company Report
|
February 2008 |
£240 |
CytImmune Sciences, Inc. -Company Report
|
February 2008 |
£240 |
Cytheris SA -Company Report
|
February 2008 |
£240 |
CyDex Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Curalogic A/S -Company Report
|
February 2008 |
£240 |
Crimson Pharma -Company Report
|
February 2008 |
£240 |
Cumberland Pharmaceuticals Inc. -Company Report
|
February 2008 |
£240 |
Curacyte AG -Company Report
|
February 2008 |
£240 |
Cytochroma Inc. -Company Report
|
February 2008 |
£240 |
Cytokine PharmaSciences Inc. -Company Report
|
February 2008 |
£240 |
DAVA Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
DAWA Limited -Company Report
|
February 2008 |
£240 |
DEY L.P. -Company Report
|
February 2008 |
£240 |
DARA BioSciences, Inc. -Company Report
|
February 2008 |
£240 |
DAIICHI SANKYO COMPANY, LIMITED -Company Report
|
February 2008 |
£240 |
Cytopia -Company Report
|
February 2008 |
£240 |
D -Pharm Ltd -Company Report
|
February 2008 |
£240 |
Creabilis Therapeutics SPA -Company Report
|
February 2008 |
£240 |
Crawford Pharmaceuticals -Company Report
|
February 2008 |
£240 |
CoMentis, Inc. -Company Report
|
February 2008 |
£240 |
Cobalt Pharmaceuticals -Company Report
|
February 2008 |
£240 |
Colby Pharmaceutical Company -Company Report
|
February 2008 |
£240 |
CoGenesys, Inc. -Company Report
|
February 2008 |
£240 |
Co -pharma Limited -Company Report
|
February 2008 |
£240 |
Clera Inc. -Company Report
|
February 2008 |
£240 |
Clonmel Healthcare Ltd. -Company Report
|
February 2008 |
£240 |
Collegium Pharmaceutical, Inc. -Company Report
|
February 2008 |
£240 |
Coloplast AS -Company Report
|
February 2008 |
£240 |
ConjuChem Inc. -Company Report
|
February 2008 |
£240 |
Cornerstone BioPharma, Inc. -Company Report
|
February 2008 |
£240 |
Cosmo Pharmaceuticals S.p.A. -Company Report
|
February 2008 |
£240 |
Concert Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Concept Pharmaceuticals Ltd. -Company Report
|
February 2008 |
£240 |
Combino Pharm -Company Report
|
February 2008 |
£240 |
Combiphar -Company Report
|
February 2008 |
£240 |
DMI BioSciences, Inc. -Company Report
|
February 2008 |
£240 |
DNAVEC Corporation -Company Report
|
February 2008 |
£240 |
DiaMedica Inc. -Company Report
|
February 2008 |
£240 |
Diabetology Ltd -Company Report
|
February 2008 |
£240 |
Diatos SA -Company Report
|
February 2008 |
£240 |
DiaKine Therapeutics, Inc. -Company Report
|
February 2008 |
£240 |
Dexcel Pharma Technologies Ltd. -Company Report
|
February 2008 |
£240 |
DeveloGen AG -Company Report
|
February 2008 |
£240 |
DexGen Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Diffusion Pharmaceuticals LLC -Company Report
|
February 2008 |
£240 |
Digna Biotech, S.L. -Company Report
|
February 2008 |
£240 |
Dong Sung Pharmaceutical Company Ltd. -Company Report
|
February 2008 |
£240 |
Dongguan Super Success Pharmaceutical CO., LTD. -Company Report
|
February 2008 |
£240 |
Dow Pharmaceutical Sciences -Company Report
|
February 2008 |
£240 |
Dong -A Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Dompe S.p.A. -Company Report
|
February 2008 |
£240 |
Din Bostad Sverige AB (formerly Tripep AB) -Company Report
|
February 2008 |
£240 |
DiverDrugs SL -Company Report
|
February 2008 |
£240 |
Desitin Arzneimittel GmbH -Company Report
|
February 2008 |
£240 |
Dermtek Pharmaceuticals Ltd -Company Report
|
February 2008 |
£240 |
Daewon Pharm. Co., Ltd. -Company Report
|
February 2008 |
£240 |
Daewoong Pharmaceutical Co. Ltd. -Company Report
|
February 2008 |
£240 |
Daihan Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Daehwa Pharm Co., Ltd. -Company Report
|
February 2008 |
£240 |
Dabur Pharma Limited -Company Report
|
February 2008 |
£240 |
DONG WHA PHARM. IND. CO., LTD. -Company Report
|
February 2008 |
£240 |
Daa pharma SA -Company Report
|
February 2008 |
£240 |
Dainippon Sumitomo Pharma Co., Ltd. -Company Report
|
February 2008 |
£240 |
Darya -Varia Group -Company Report
|
February 2008 |
£240 |
Depsons Pharma -Company Report
|
February 2008 |
£240 |
Derma UK Ltd -Company Report
|
February 2008 |
£240 |
Dermik Laboratories -Company Report
|
February 2008 |
£240 |
Del Laboratories, Inc. -Company Report
|
February 2008 |
£240 |
Debiopharm Group -Company Report
|
February 2008 |
£240 |
Dawnrays Pharmaceutical (Holdings) Ltd. -Company Report
|
February 2008 |
£240 |
DaySpring Pharma -Company Report
|
February 2008 |
£240 |
Wendt -Bristol Health Services -Financial Company Report
|
February 2008 |
£110 |
WellPoint Inc -Financial Company Report
|
February 2008 |
£110 |
ATCO Laboratories Limited -Company Report
|
February 2008 |
£240 |
AUSTRIANOVA Biotechnology GmbH -Company Report
|
February 2008 |
£240 |
AbGenomics Corporation -Company Report
|
February 2008 |
£240 |
ASKA Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
ASIA PHARMACEUTICAL INDUSTRIES -Company Report
|
February 2008 |
£240 |
AOP Orphan Pharmaceuticals AG -Company Report
|
February 2008 |
£240 |
ARIUS Research Inc -Company Report
|
February 2008 |
£240 |
ASAC PHARMA -Company Report
|
February 2008 |
£240 |
Abbott India Limited -Company Report
|
February 2008 |
£240 |
Abdi Ibrahim -Company Report
|
February 2008 |
£240 |
Acacia Pharma Ltd -Company Report
|
February 2008 |
£240 |
Acceleron Pharma, Inc. -Company Report
|
February 2008 |
£240 |
Acme Laboratories Ltd. -Company Report
|
February 2008 |
£240 |
Aburaihan Pharmaceutical Co. -Company Report
|
February 2008 |
£240 |
Ablynx nv -Company Report
|
February 2008 |
£240 |
Abigo Medical -Company Report
|
February 2008 |
£240 |
Abiogen Pharma S.p.A. -Company Report
|
February 2008 |
£240 |
AMT BV -Company Report
|
February 2008 |
£240 |
AMSON VACCINES & PHARMA (PVT) LTD -Company Report
|
February 2008 |
£240 |
AEXIM Pharmaceuticals Ltd -Company Report
|
February 2008 |
£240 |
AFLOFARM -Company Report
|
February 2008 |
£240 |
AFT Pharmaceuticals Pty Ltd -Company Report
|
February 2008 |
£240 |
ACE Pharmaceuticals BV -Company Report
|
February 2008 |
£240 |
ACE BioSciences A/S -Company Report
|
February 2008 |
£240 |
A.N.B. Laboratories Co., Ltd. -Company Report
|
February 2008 |
£240 |
AC HELCOR Group -Company Report
|
February 2008 |
£240 |
AGI Therapeutics plc -Company Report
|
February 2008 |
£240 |
AGIO PHARMACEUTICALS LTD. -Company Report
|
February 2008 |
£240 |
ALIUD® PHARMA GmbH & CO. Kg -Company Report
|
February 2008 |
£240 |
ALK -Abello A/S -Company Report
|
February 2008 |
£240 |
ALKEM LABORATORIES LTD. -Company Report
|
February 2008 |
£240 |
ALFA WASSERMANN S.p.A. -Company Report
|
February 2008 |
£240 |
ALCO Pharma Ltd. -Company Report
|
February 2008 |
£240 |
AIM Therapeutics Inc. -Company Report
|
February 2008 |
£240 |
AKVION -Company Report
|
February 2008 |
£240 |
Acme Pharmaceuticals -Company Report
|
February 2008 |
£240 |
Acologix, Inc. -Company Report
|
February 2008 |
£240 |
Ahn -Gook Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Ajanta Pharma Limited -Company Report
|
February 2008 |
£240 |
Ajinomoto Co., Inc. -Company Report
|
February 2008 |
£240 |
Affimed Therapeutics AG -Company Report
|
February 2008 |
£240 |
Afecta Pharmaceuticals Inc. -Company Report
|
February 2008 |
£240 |
Aero Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Aerovance, Inc. -Company Report
|
February 2008 |
£240 |
Alaven Pharmaceutical LLC -Company Report
|
February 2008 |
£240 |
Alba Therapeutics Corporation -Company Report
|
February 2008 |
£240 |
Aleppo Pharmaceutical Industries, L.L.C. -Company Report
|
February 2008 |
£240 |
Alethia Biotherapeutics Inc. -Company Report
|
February 2008 |
£240 |
Alfresa Pharma Corporation -Company Report
|
February 2008 |
£240 |
Alembic Limited -Company Report
|
February 2008 |
£240 |
Alchemgen Therapeutics Inc. -Company Report
|
February 2008 |
£240 |
Albert David Limited -Company Report
|
February 2008 |
£240 |
Alborz Darou Co. -Company Report
|
February 2008 |
£240 |
Aegera Therapeutics Inc. -Company Report
|
February 2008 |
£240 |
Advik Laboratories Ltd. -Company Report
|
February 2008 |
£240 |
ActivBiotics (formerly Merlin Technologies, Inc.) -Company Report
|
February 2008 |
£240 |
Active Biotech -Company Report
|
February 2008 |
£240 |
AdPharma, Inc. -Company Report
|
February 2008 |
£240 |
Action Pharma A/S -Company Report
|
February 2008 |
£240 |
Actavis -Company Report
|
February 2008 |
£240 |
Acrux Limited -Company Report
|
February 2008 |
£240 |
AcryMed -Company Report
|
February 2008 |
£240 |
Adamed Sp. z o.o. -Company Report
|
February 2008 |
£240 |
Adcock Ingram Limited -Company Report
|
February 2008 |
£240 |
Adonis Laboratories Pvt. Ltd. -Company Report
|
February 2008 |
£240 |
Advanced Medical Solutions Group plc -Company Report
|
February 2008 |
£240 |
Advantagene, Inc. -Company Report
|
February 2008 |
£240 |
Aderis Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Adenosine Therapeutics, LLC -Company Report
|
February 2008 |
£240 |
Addex Pharmaceuticals SA -Company Report
|
February 2008 |
£240 |
Adelco -Company Report
|
February 2008 |
£240 |
7TM Pharma A/S -Company Report
|
February 2008 |
£240 |
4SC AG -Company Report
|
February 2008 |
£240 |
Emisphere Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Empyrean Bioscience Inc. -Financial Company Report
|
February 2008 |
£110 |
Encision Inc -Financial Company Report
|
February 2008 |
£110 |
Emeritus Corporation -Financial Company Report
|
February 2008 |
£110 |
Emergent BioSolutions Inc -Financial Company Report
|
February 2008 |
£110 |
Embryo Development Corp. -Financial Company Report
|
February 2008 |
£110 |
Emergency Filtration Products Inc -Financial Company Report
|
February 2008 |
£110 |
Emergency Medical Services Corp. -Financial Company Report
|
February 2008 |
£110 |
Encorium Group Inc -Financial Company Report
|
February 2008 |
£110 |
Encysive Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
EnteroMedics, Inc. -Financial Company Report
|
February 2008 |
£110 |
EntreMed Inc -Financial Company Report
|
February 2008 |
£110 |
Enzo Biochem Inc -Financial Company Report
|
February 2008 |
£110 |
Enhance Biotech Inc -Financial Company Report
|
February 2008 |
£110 |
Endovasc Inc (NV) -Financial Company Report
|
February 2008 |
£110 |
Endo Pharmaceuticals Holdings Inc -Financial Company Report
|
February 2008 |
£110 |
Endologix Inc -Financial Company Report
|
February 2008 |
£110 |
Emageon Inc -Financial Company Report
|
February 2008 |
£110 |
Elron Electronic Industries Ltd -Financial Company Report
|
February 2008 |
£110 |
EGM International, Inc. -Financial Company Report
|
February 2008 |
£110 |
ENDOcare Inc -Financial Company Report
|
February 2008 |
£110 |
EP MedSystems Inc -Financial Company Report
|
February 2008 |
£110 |
EDEN Bioscience Corp. -Financial Company Report
|
February 2008 |
£110 |
EDAP TMS SA ADR -Financial Company Report
|
February 2008 |
£110 |
Dynavax Technologies Corp -Financial Company Report
|
February 2008 |
£110 |
E Z EM Inc -Financial Company Report
|
February 2008 |
£110 |
EPIX Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Eastman Chemical Company -Financial Company Report
|
February 2008 |
£110 |
Elan Corp Plc -Financial Company Report
|
February 2008 |
£110 |
Electro Catheter Corp -Financial Company Report
|
February 2008 |
£110 |
Elite Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Eisai Co Ltd -Financial Company Report
|
February 2008 |
£110 |
Edwards Lifesciences Corporation -Financial Company Report
|
February 2008 |
£110 |
Echo Therapeutics, Inc -Financial Company Report
|
February 2008 |
£110 |
EchoCath Inc -Financial Company Report
|
February 2008 |
£110 |
Enzon Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
EpiCept Corp -Financial Company Report
|
February 2008 |
£110 |
Quest Diagnostics Inc -Financial Company Report
|
February 2008 |
£110 |
SCOLR Pharma Inc -Financial Company Report
|
February 2008 |
£110 |
Spectral Diagnostics Inc -Financial Company Report
|
February 2008 |
£110 |
Neuralstem Inc. -Financial Company Report
|
February 2008 |
£110 |
Minrad International Inc -Financial Company Report
|
February 2008 |
£110 |
Labopharm Inc -Financial Company Report
|
February 2008 |
£110 |
MedCom USA Inc -Financial Company Report
|
February 2008 |
£110 |
Syneron Medical Ltd -Financial Company Report
|
February 2008 |
£110 |
VISICU Inc -Financial Company Report
|
February 2008 |
£110 |
ev3 Inc -Financial Company Report
|
February 2008 |
£110 |
Let's Talk Recovery Inc -Financial Company Report
|
February 2008 |
£110 |
Nature's Sunshine Products Inc -Financial Company Report
|
February 2008 |
£110 |
etrials Worldwide Inc -Financial Company Report
|
February 2008 |
£110 |
eResearchTechnology Inc -Financial Company Report
|
February 2008 |
£110 |
XELR8, Inc. -Financial Company Report
|
February 2008 |
£110 |
deCODE genetics Inc -Financial Company Report
|
February 2008 |
£110 |
I -trax Inc -Financial Company Report
|
February 2008 |
£110 |
Human Pheromone Sciences Inc -Financial Company Report
|
February 2008 |
£110 |
Estee Lauder Cos Inc -Financial Company Report
|
February 2008 |
£110 |
Eugene Science Inc -Financial Company Report
|
February 2008 |
£110 |
Eurand N.V. -Financial Company Report
|
February 2008 |
£110 |
Escalon Medical Corp -Financial Company Report
|
February 2008 |
£110 |
Eqitx Ltd -Financial Company Report
|
February 2008 |
£110 |
Epicore BioNetworks Inc -Financial Company Report
|
February 2008 |
£110 |
Epigenomics AG -Financial Company Report
|
February 2008 |
£110 |
Exact Sciences Corporation -Financial Company Report
|
February 2008 |
£110 |
Exactech Inc -Financial Company Report
|
February 2008 |
£110 |
Flamel Technologies SA ADS -Financial Company Report
|
February 2008 |
£110 |
Genentech Inc -Financial Company Report
|
February 2008 |
£110 |
HearUSA Inc -Financial Company Report
|
February 2008 |
£110 |
FMC Corporation -Financial Company Report
|
February 2008 |
£110 |
Extendicare Inc -Financial Company Report
|
February 2008 |
£110 |
Exelixis Inc -Financial Company Report
|
February 2008 |
£110 |
Express Scripts Inc -Financial Company Report
|
February 2008 |
£110 |
Algeta ASA -Company Report
|
February 2008 |
£240 |
Alizyme plc -Company Report
|
February 2008 |
£240 |
Schiff Nutrition International Inc -Financial Company Report
|
February 2008 |
£110 |
United Therapeutics Corporation -Financial Company Report
|
February 2008 |
£110 |
Utah Medical Products Inc -Financial Company Report
|
February 2008 |
£110 |
Phosphagenics Ltd. -Financial Company Report
|
February 2008 |
£110 |
Pharmasset, Inc. -Financial Company Report
|
February 2008 |
£110 |
Meridian Bioscience Inc -Financial Company Report
|
February 2008 |
£110 |
Optical Sensors Incorporated -Financial Company Report
|
February 2008 |
£110 |
Orthovita Inc -Financial Company Report
|
February 2008 |
£110 |
VCA Antech Inc -Financial Company Report
|
February 2008 |
£110 |
VIA Pharmaceuticals, Inc. -Financial Company Report
|
February 2008 |
£110 |
Varian Inc -Financial Company Report
|
February 2008 |
£110 |
Varian Medical Systems Inc -Financial Company Report
|
February 2008 |
£110 |
Vascular Solutions Inc -Financial Company Report
|
February 2008 |
£110 |
Vanda Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Valhi Inc -Financial Company Report
|
February 2008 |
£110 |
VIVUS Inc -Financial Company Report
|
February 2008 |
£110 |
Valeant Pharmaceuticals International -Financial Company Report
|
February 2008 |
£110 |
Futurebiotics Inc -Financial Company Report
|
February 2008 |
£110 |
Excel Technology Inc -Financial Company Report
|
February 2008 |
£110 |
Bakhtar Bioshimi Co. -Company Report
|
February 2008 |
£240 |
Banner Pharmacaps -Company Report
|
February 2008 |
£240 |
Barbeau Pharma Inc. -Company Report
|
February 2008 |
£240 |
BELCO PHARMA -Company Report
|
February 2008 |
£240 |
BARAKAT Pharmaceutical Industries -Company Report
|
February 2008 |
£240 |
B.F. Ascher & Co. Inc. -Company Report
|
February 2008 |
£240 |
BAL PHARMA LTD. -Company Report
|
February 2008 |
£240 |
Bayer HealthCare Pharmaceuticals (formerly Berlex, Inc.) -Company Report
|
February 2008 |
£240 |
Beacon Pharmaceuticals Ltd -Company Report
|
February 2008 |
£240 |
Beijing Zizhu Pharmaceutical Co.,Ltd -Company Report
|
February 2008 |
£240 |
Benesis Corporation -Company Report
|
February 2008 |
£240 |
DENTSPLY International Inc -Financial Company Report
|
February 2008 |
£110 |
Beijing SL Pharmaceutical Co., Ltd -Company Report
|
February 2008 |
£240 |
Beijing Pason Pharmaceuticals Inc -Company Report
|
February 2008 |
£240 |
Beacons Pharmaceuticals Pte Ltd -Company Report
|
February 2008 |
£240 |
Bedford Laboratories -Company Report
|
February 2008 |
£240 |
Vaso Active Pharmaceuticals -Financial Company Report
|
February 2008 |
£110 |
Vasogen Inc -Financial Company Report
|
February 2008 |
£110 |
Vital Living Inc -Financial Company Report
|
February 2008 |
£110 |
Vital Signs Inc -Financial Company Report
|
February 2008 |
£110 |
Vitalstate Inc. -Financial Company Report
|
February 2008 |
£110 |
Vital Images Inc -Financial Company Report
|
February 2008 |
£110 |
Vision -Sciences Inc -Financial Company Report
|
February 2008 |
£110 |
Viropro Inc -Financial Company Report
|
February 2008 |
£110 |
VirtualScopics Inc -Financial Company Report
|
February 2008 |
£110 |
Vitro Diagnostics Inc -Financial Company Report
|
February 2008 |
£110 |
Vnus Medical Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Warner Chilcott Limited -Financial Company Report
|
February 2008 |
£110 |
Waters Corp -Financial Company Report
|
February 2008 |
£110 |
Watson Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Walgreen Co -Financial Company Report
|
February 2008 |
£110 |
Vyteris Holdings (Nevada) Inc -Financial Company Report
|
February 2008 |
£110 |
Volcano Corp -Financial Company Report
|
February 2008 |
£110 |
Vyrex Corp -Financial Company Report
|
February 2008 |
£110 |
Viropharma Inc -Financial Company Report
|
February 2008 |
£110 |
Viral Genetics Inc -Financial Company Report
|
February 2008 |
£110 |
Ventracor Ltd -Financial Company Report
|
February 2008 |
£110 |
Verenium Corp. -Financial Company Report
|
February 2008 |
£110 |
Verex Laboratories, Inc. -Financial Company Report
|
February 2008 |
£110 |
Ventana Medical Systems Inc -Financial Company Report
|
February 2008 |
£110 |
Velcera Inc. -Financial Company Report
|
February 2008 |
£110 |
Vasomedical Inc -Financial Company Report
|
February 2008 |
£110 |
VaxGen Inc -Financial Company Report
|
February 2008 |
£110 |
Vermillion, Inc. -Financial Company Report
|
February 2008 |
£110 |
Vernalis Plc ADR -Financial Company Report
|
February 2008 |
£110 |
VioQuest Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Vion Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Viragen Inc -Financial Company Report
|
February 2008 |
£110 |
Viking Systems Inc -Financial Company Report
|
February 2008 |
£110 |
Vicon Fiber Optics Corp. -Financial Company Report
|
February 2008 |
£110 |
Vertex Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Vical Inc -Financial Company Report
|
February 2008 |
£110 |
Azur Pharma Limited -Company Report
|
February 2008 |
£240 |
Azevan Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Anacor Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Anadis, Ltd. -Company Report
|
February 2008 |
£240 |
AndroScience Corporation -Company Report
|
February 2008 |
£240 |
AnGes MG, Inc. -Company Report
|
February 2008 |
£240 |
Amura Holdings Ltd. -Company Report
|
February 2008 |
£240 |
Amoun Pharmaceuticals Co. S.A.E -Company Report
|
February 2008 |
£240 |
Amphastar Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
AmpliMed Corporation -Company Report
|
February 2008 |
£240 |
Androclus Therapeutics -Company Report
|
February 2008 |
£240 |
Angelini -Company Report
|
February 2008 |
£240 |
Antisense Pharma GmbH -Company Report
|
February 2008 |
£240 |
Antisense Therapeutics Limited -Company Report
|
February 2008 |
£240 |
Antyra, Inc. -Company Report
|
February 2008 |
£240 |
Antipodean Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Antibe Therapeutics Inc. -Company Report
|
February 2008 |
£240 |
Angion Biomedica Corp. -Company Report
|
February 2008 |
£240 |
Anthera Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Amkor Pharma, Inc. -Company Report
|
February 2008 |
£240 |
Amin Pharmaceutical Company -Company Report
|
February 2008 |
£240 |
Altea Therapeutics -Company Report
|
February 2008 |
£240 |
Alterna LLC -Company Report
|
February 2008 |
£240 |
Altor BioScience Corp. -Company Report
|
February 2008 |
£240 |
Altaire Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Allon Therapeutics Inc. -Company Report
|
February 2008 |
£240 |
Alliance Pharma plc -Company Report
|
February 2008 |
£240 |
Allied Chemicals and Pharmaceuticals Private Limited -Company Report
|
February 2008 |
£240 |
Alva -Amco Pharmacal Cos., Inc. -Company Report
|
February 2008 |
£240 |
Amarin Technologies S.A. -Company Report
|
February 2008 |
£240 |
American Biologics -Company Report
|
February 2008 |
£240 |
American Regent, Inc. -Company Report
|
February 2008 |
£240 |
Amico laboratories Limited -Company Report
|
February 2008 |
£240 |
Ambrilia Biopharma Inc. (formerly Procyon Biopharma Inc.) -Company Report
|
February 2008 |
£240 |
Ambit Biosciences Corporation -Company Report
|
February 2008 |
£240 |
Ambalal Sarabhai Enterprises -Company Report
|
February 2008 |
£240 |
Ambee Pharmaceuticals Ltd. -Company Report
|
February 2008 |
£240 |
Aphios Corporation -Company Report
|
February 2008 |
£240 |
Apipol -Farma Ltd -Company Report
|
February 2008 |
£240 |
Astion Pharma A/S -Company Report
|
February 2008 |
£240 |
Asubio Pharma Co., Ltd. -Company Report
|
February 2008 |
£240 |
Athlon Pharmaceuticals -Company Report
|
February 2008 |
£240 |
Astex Therapeutics -Company Report
|
February 2008 |
£240 |
AsiaPharm Group Ltd. -Company Report
|
February 2008 |
£240 |
Ascend Therapeutics, Inc. -Company Report
|
February 2008 |
£240 |
Ascenta Therapeutics, Inc. -Company Report
|
February 2008 |
£240 |
Atley Pharmaceuticals, Inc -Company Report
|
February 2008 |
£240 |
Atopix Pharmaceuticals Corporation -Company Report
|
February 2008 |
£240 |
Avera Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Avir Green Hills Biotechnology AG -Company Report
|
February 2008 |
£240 |
Avontec GmbH -Company Report
|
February 2008 |
£240 |
Avantogen Limited (formerly Australian Cancer Technology Limited) -Company Report
|
February 2008 |
£240 |
Aurora Pharmaceuticals Pty Ltd. -Company Report
|
February 2008 |
£240 |
Attenuon, L.L.C. -Company Report
|
February 2008 |
£240 |
Aurobindo Pharma Ltd. -Company Report
|
February 2008 |
£240 |
Asahi Kasei Corporation -Company Report
|
February 2008 |
£240 |
Arvind Remedies Ltd -Company Report
|
February 2008 |
£240 |
Archemix Corp. -Company Report
|
February 2008 |
£240 |
Archimedes Pharma Limited -Company Report
|
February 2008 |
£240 |
Ardana plc -Company Report
|
February 2008 |
£240 |
Arachnova Limited -Company Report
|
February 2008 |
£240 |
AquaGenyx Pharmaceuticals Inc. -Company Report
|
February 2008 |
£240 |
ApopLogic Pharmaceuticals, LLC -Company Report
|
February 2008 |
£240 |
Apotex Inc. -Company Report
|
February 2008 |
£240 |
Argos Therapeutics, Inc., (formerly Merix Bioscience) -Company Report
|
February 2008 |
£240 |
Arisaph Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Arpida Ltd. -Company Report
|
February 2008 |
£240 |
Arriva Pharmaceuticals, Inc -Company Report
|
February 2008 |
£240 |
Arrow Generics Ltd -Company Report
|
February 2008 |
£240 |
ArmaGen Technologies, Inc. -Company Report
|
February 2008 |
£240 |
Ark Therapeutics Group plc -Company Report
|
February 2008 |
£240 |
Aristo Pharmaceuticals Pvt. Ltd. -Company Report
|
February 2008 |
£240 |
Aristopharma Ltd. -Company Report
|
February 2008 |
£240 |
Flamingo Pharmaceuticals Ltd. -Company Report
|
February 2008 |
£240 |
Fleming Pharmaceuticals -Company Report
|
February 2008 |
£240 |
Stragen Pharma S.A -Company Report
|
February 2008 |
£240 |
Summers Labs, Inc. -Company Report
|
February 2008 |
£240 |
Summit plc -Company Report
|
February 2008 |
£240 |
Stiefel Laboratories, Inc. -Company Report
|
February 2008 |
£240 |
Sterling Lab -Company Report
|
February 2008 |
£240 |
Standard Chem. & Pharm. Co., Ltd. -Company Report
|
February 2008 |
£240 |
Star Laboratories (Pvt) Ltd. -Company Report
|
February 2008 |
£240 |
Stemline Therapeutics, Inc. -Company Report
|
February 2008 |
£240 |
Sun Pharmaceutical Industries Ltd. -Company Report
|
February 2008 |
£240 |
Sunij Pharma -Company Report
|
February 2008 |
£240 |
Supratek Pharma Inc -Company Report
|
February 2008 |
£240 |
Surface Logix, Inc. -Company Report
|
February 2008 |
£240 |
Symphogen A/S -Company Report
|
February 2008 |
£240 |
Sunway Biotech Co.Ltd. -Company Report
|
February 2008 |
£240 |
Sunward Pharmaceutical Pte Ltd -Company Report
|
February 2008 |
£240 |
Sunrise Pharmaceutical, Inc. -Company Report
|
February 2008 |
£240 |
Suntory Limited -Company Report
|
February 2008 |
£240 |
Stallion Laboratories Pvt. Ltd. -Company Report
|
February 2008 |
£240 |
St. Charles Pharmaceuticals -Company Report
|
February 2008 |
£240 |
Somatico Laboratories Pvt. Ltd. -Company Report
|
February 2008 |
£240 |
Sopharma JSCo. -Company Report
|
February 2008 |
£240 |
Sosei Group Corporation -Company Report
|
February 2008 |
£240 |
Solvay S.A. -Company Report
|
February 2008 |
£240 |
Snow Brand Milk Products Co., Ltd. -Company Report
|
February 2008 |
£240 |
Sinclair Pharma plc -Company Report
|
February 2008 |
£240 |
SkinMedica -Company Report
|
February 2008 |
£240 |
Southwest Synthetic Pharmaceutical Corporation Ltd. -Company Report
|
February 2008 |
£240 |
Sparsh Bio -Tech Pvt. Ltd. -Company Report
|
February 2008 |
£240 |
Spirig Pharma Ltd. -Company Report
|
February 2008 |
£240 |
Spirogen Ltd. -Company Report
|
February 2008 |
£240 |
Square Pharmaceuticals Ltd. -Company Report
|
February 2008 |
£240 |
Spherics, Inc -Company Report
|
February 2008 |
£240 |
Speedel -Company Report
|
February 2008 |
£240 |
Speciality European Pharma Limited -Company Report
|
February 2008 |
£240 |
Specifar Pharmaceuticals S.A. -Company Report
|
February 2008 |
£240 |
SynZyme Technologies LLC -Company Report
|
February 2008 |
£240 |
Syncom Formulations (India) Ltd -Company Report
|
February 2008 |
£240 |
TRx Pharma -Company Report
|
February 2008 |
£240 |
TSUMURA & CO. -Company Report
|
February 2008 |
£240 |
TTK Healthcare Ltd -Company Report
|
February 2008 |
£240 |
TRION Pharma GmbH -Company Report
|
February 2008 |
£240 |
TRB CHEMEDICA INTERNATIONAL SA -Company Report
|
February 2008 |
£240 |
TOYAMA CHEMICAL CO.,LTD. -Company Report
|
February 2008 |
£240 |
TRACON Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
TTY BioPharm -Company Report
|
February 2008 |
£240 |
Tablets (India) Limited -Company Report
|
February 2008 |
£240 |
Taiwan Panbiotic Laboratories Co. Ltd. -Company Report
|
February 2008 |
£240 |
Takeda Pharmaceutical Company Limited -Company Report
|
February 2008 |
£240 |
Talecris Biotherapeutics -Company Report
|
February 2008 |
£240 |
Taiwan Liposome Company -Company Report
|
February 2008 |
£240 |
Taisho Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
TaiGen Biotechnology Co., Ltd. -Company Report
|
February 2008 |
£240 |
Taiho Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
TOSC INTERNATIONAL PVT. LTD. -Company Report
|
February 2008 |
£240 |
TOPIGEN Pharmaceuticals Inc. -Company Report
|
February 2008 |
£240 |
Synpac -Kingdom Pharmaceuticals Co Ltd -Company Report
|
February 2008 |
£240 |
Synteza Ltd -Company Report
|
February 2008 |
£240 |
Synthon Pharmaceuticals, Ltd. -Company Report
|
February 2008 |
£240 |
Synosia Therapeutics (formerly Synosis Therapeutics) -Company Report
|
February 2008 |
£240 |
Synokem Pharmaceuticals Limited -Company Report
|
February 2008 |
£240 |
Synmedic Laboratories -Company Report
|
February 2008 |
£240 |
Synmosa Biopharma Corporation -Company Report
|
February 2008 |
£240 |
Syntopix Group plc -Company Report
|
February 2008 |
£240 |
Syntrix BioSystems -Company Report
|
February 2008 |
£240 |
THERABEL Group -Company Report
|
February 2008 |
£240 |
TIDAL LABORATORIES PVT LIMITED -Company Report
|
February 2008 |
£240 |
TMRC Co., Ltd. -Company Report
|
February 2008 |
£240 |
THEMIS MEDICARE LTD. -Company Report
|
February 2008 |
£240 |
THEMIS LABORATORIES PRIVATE LTD -Company Report
|
February 2008 |
£240 |
T3A Industrial -Company Report
|
February 2008 |
£240 |
TAP Pharmaceutical Products Inc. -Company Report
|
February 2008 |
£240 |
Silence Therapeutics plc (formerly SR Pharma plc) -Company Report
|
February 2008 |
£240 |
Sigma Pharmaceuticals Limited -Company Report
|
February 2008 |
£240 |
SKYMAX LABORATORIES PVT. LTD. -Company Report
|
February 2008 |
£240 |
SRS Pharmaceuticals Pvt. Ltd. -Company Report
|
February 2008 |
£240 |
SSP CO., LTD. -Company Report
|
February 2008 |
£240 |
SK Chemicals Life Science (formerly Dong Shin Pharmaceutical Co., Ltd.) -Company Report
|
February 2008 |
£240 |
SK Bio -Pharmaceuticals -Company Report
|
February 2008 |
£240 |
SICOR Biotech UAB -Company Report
|
February 2008 |
£240 |
SIFI S.p.A. -Company Report
|
February 2008 |
£240 |
SIGMA LABORATORIES PVT. LTD. -Company Report
|
February 2008 |
£240 |
SVUS Pharma a. s. -Company Report
|
February 2008 |
£240 |
SWEDISH ORPHAN A/S -Company Report
|
February 2008 |
£240 |
Sam Chun Dang Pharm. Co.,Ltd -Company Report
|
February 2008 |
£240 |
Samyang Corporation -Company Report
|
February 2008 |
£240 |
Sanbe Farma -Company Report
|
February 2008 |
£240 |
Saga Laboratories -Company Report
|
February 2008 |
£240 |
Saegis Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
SYSTOPIC LABORATORIES PVT. LTD. -Company Report
|
February 2008 |
£240 |
Saba Ilac Sanayii ve Ticaret A.S. -Company Report
|
February 2008 |
£240 |
SHALAKS PHARMACEUTICALS PVT. LTD. -Company Report
|
February 2008 |
£240 |
SGPharma Pvt. Ltd. -Company Report
|
February 2008 |
£240 |
Revance Therapeutics, Inc. -Company Report
|
February 2008 |
£240 |
Rib -X Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Rimonyx Pharmaceuticals Ltd. -Company Report
|
February 2008 |
£240 |
Resverlogix Corp. -Company Report
|
February 2008 |
£240 |
Rephco Laboratories Ltd. -Company Report
|
February 2008 |
£240 |
Reliance Life Sciences Pvt. Ltd. -Company Report
|
February 2008 |
£240 |
Renovo Ltd. -Company Report
|
February 2008 |
£240 |
Romark Laboratories, L.C. -Company Report
|
February 2008 |
£240 |
Rosedale Therapeutics -Company Report
|
February 2008 |
£240 |
SAMARTH PHARMA PVT. LTD. -Company Report
|
February 2008 |
£240 |
SAWAI PHARMACEUTICAL CO.,LTD. -Company Report
|
February 2008 |
£240 |
SERB Laboratories -Company Report
|
February 2008 |
£240 |
S.L.A. Pharma AG -Company Report
|
February 2008 |
£240 |
Rusan Pharma Ltd. -Company Report
|
February 2008 |
£240 |
Rosemont Pharmaceuticals Ltd -Company Report
|
February 2008 |
£240 |
Rottapharm SpA -Company Report
|
February 2008 |
£240 |
Sandoz International GmbH -Company Report
|
February 2008 |
£240 |
Sanochemia Pharmazeutika AG -Company Report
|
February 2008 |
£240 |
Shaklee Corporation -Company Report
|
February 2008 |
£240 |
Shalina Laboratories Pvt Ltd. -Company Report
|
February 2008 |
£240 |
Shanghai Dongbao Biopharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Sevapharma a. s. -Company Report
|
February 2008 |
£240 |
Serum Institute Of India Ltd. -Company Report
|
February 2008 |
£240 |
Serenex, Inc. -Company Report
|
February 2008 |
£240 |
Serentis Ltd -Company Report
|
February 2008 |
£240 |
Shanghai Fosun Pharmaceutical Group Co., Ltd. -Company Report
|
February 2008 |
£240 |
Shanghai Harvest Pharmaceutical Co.Ltd -Company Report
|
February 2008 |
£240 |
Shionogi & Co., Ltd. -Company Report
|
February 2008 |
£240 |
Shrooq PHARMA (PVT.) LTD. -Company Report
|
February 2008 |
£240 |
Sigma -Tau S.p.A. -Company Report
|
February 2008 |
£240 |
Shinpoong Pharm Co., Ltd. -Company Report
|
February 2008 |
£240 |
Shimoda Biotech -Company Report
|
February 2008 |
£240 |
Shanghai Sunve Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Shantha Biotechnics -Company Report
|
February 2008 |
£240 |
Sequella, Inc. -Company Report
|
February 2008 |
£240 |
Senju Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Sanwa Kagaku Kenkyusho Co., Ltd. -Company Report
|
February 2008 |
£240 |
Sareum Ltd -Company Report
|
February 2008 |
£240 |
Sato Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Santhera Pharmaceuticals AG -Company Report
|
February 2008 |
£240 |
Santen Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Sanofi Pasteur -Company Report
|
February 2008 |
£240 |
Santaris Pharma A/S -Company Report
|
February 2008 |
£240 |
Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) -Company Report
|
February 2008 |
£240 |
Scancell Limited -Company Report
|
February 2008 |
£240 |
Sedona Laboratories, Inc. -Company Report
|
February 2008 |
£240 |
Seikagaku Corporation -Company Report
|
February 2008 |
£240 |
Semafore Pharmaceuticals (formerly ComChem Technologies) -Company Report
|
February 2008 |
£240 |
Searle Pakistan Pvt. LTD. -Company Report
|
February 2008 |
£240 |
Scios Inc. -Company Report
|
February 2008 |
£240 |
SciGen Limited -Company Report
|
February 2008 |
£240 |
Scil Technology GmbH -Company Report
|
February 2008 |
£240 |
Tampei Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
TargeGen, Inc. -Company Report
|
February 2008 |
£240 |
Wallace Pharmaceuticals Ltd. -Company Report
|
February 2008 |
£240 |
Warren Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Waymade Healthcare plc -Company Report
|
February 2008 |
£240 |
Wakamoto Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
WOCKHARDT LIMITED -Company Report
|
February 2008 |
£240 |
WEX Pharmaceuticals Inc. -Company Report
|
February 2008 |
£240 |
WILEX AG -Company Report
|
February 2008 |
£240 |
WINGS PHARMACEUTICALS PVT. LTD -Company Report
|
February 2008 |
£240 |
Wellspring Pharmaceutical Corporation -Company Report
|
February 2008 |
£240 |
Wellstat Biologics Corporation -Company Report
|
February 2008 |
£240 |
Winsome Laboratories Pvt Ltd. -Company Report
|
February 2008 |
£240 |
Winston Laboratories, Inc. -Company Report
|
February 2008 |
£240 |
X -GEN Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Windlas Biotech Limited -Company Report
|
February 2008 |
£240 |
Will -Pharma -Company Report
|
February 2008 |
£240 |
Wellstat Therapeutics Corporation -Company Report
|
February 2008 |
£240 |
WhanIn Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Vivier Pharma Inc. -Company Report
|
February 2008 |
£240 |
Viventia Biotech, Inc. -Company Report
|
February 2008 |
£240 |
Victus Inc. -Company Report
|
February 2008 |
£240 |
Vida Labs Limited -Company Report
|
February 2008 |
£240 |
Viralytics Ltd (formerly Psiron Ltd) -Company Report
|
February 2008 |
£240 |
Victory Pharma, Inc. -Company Report
|
February 2008 |
£240 |
VersaPharm Incorporated -Company Report
|
February 2008 |
£240 |
Venus Remedies Limited -Company Report
|
February 2008 |
£240 |
Veropharm -Company Report
|
February 2008 |
£240 |
Virium Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
ViroMed Co., Ltd -Company Report
|
February 2008 |
£240 |
VistaGen Therapeutics, Inc. -Company Report
|
February 2008 |
£240 |
Vitae Pharmaceuticals, Inc. (formerly Concurrent Pharmaceuticals) -Company Report
|
February 2008 |
£240 |
Vital BioTech Holdings Ltd -Company Report
|
February 2008 |
£240 |
Vista Pharmaceuticals -Company Report
|
February 2008 |
£240 |
Vision Pharma, LLC -Company Report
|
February 2008 |
£240 |
ViroTarg Pty Ltd -Company Report
|
February 2008 |
£240 |
Viron Therapeutics Inc -Company Report
|
February 2008 |
£240 |
Xanodyne Pharmaceuticals, Inc. (formerly Xanodyne Pharmacal) -Company Report
|
February 2008 |
£240 |
Xanthus Pharmaceuticals, Inc. (formerly Xanthus Life Sciences) -Company Report
|
February 2008 |
£240 |
Zealand Pharma A/S -Company Report
|
February 2008 |
£240 |
Zedawn Formulations Private Limited -Company Report
|
February 2008 |
£240 |
Zenotech Laboratories Ltd. -Company Report
|
February 2008 |
£240 |
Zambon Group -Company Report
|
February 2008 |
£240 |
Zahravi Pharmaceutical Company -Company Report
|
February 2008 |
£240 |
Yung Shin Pharmaceutical -Company Report
|
February 2008 |
£240 |
ZARS Pharma -Company Report
|
February 2008 |
£240 |
Zentiva, a.s. (formerly Leciva a.s.) -Company Report
|
February 2008 |
£240 |
Zenyaku Kogyo Co. Ltd. -Company Report
|
February 2008 |
£240 |
Zyber Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Zydus Cadila Healthcare Limited -Company Report
|
February 2008 |
£240 |
Zymenex A/S -Company Report
|
February 2008 |
£240 |
Zion Pharmaceuticals (India) -Company Report
|
February 2008 |
£240 |
Zhuzhou Qianjin Pharmaceutical Co.,Ltd -Company Report
|
February 2008 |
£240 |
Zeria Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Zhejiang Huahai Pharmaceutical Co.,Ltd -Company Report
|
February 2008 |
£240 |
Yuhan Corporation -Company Report
|
February 2008 |
£240 |
YuYu Inc. -Company Report
|
February 2008 |
£240 |
Xepa -Soul Pattinson (Malaysia) Sdn Bhd -Company Report
|
February 2008 |
£240 |
Xerion Pharmaceuticals AG -Company Report
|
February 2008 |
£240 |
Xigen S.A. -Company Report
|
February 2008 |
£240 |
Xention Limited (formerly Xention Discovery Ltd) -Company Report
|
February 2008 |
£240 |
Xenon Pharmaceuticals Inc. -Company Report
|
February 2008 |
£240 |
Xencor -Company Report
|
February 2008 |
£240 |
Xenon Pharma. -Company Report
|
February 2008 |
£240 |
Xytis, Inc. -Company Report
|
February 2008 |
£240 |
YAMAZAKI TEIKOKUDO CO., LTD. -Company Report
|
February 2008 |
£240 |
Y''s Therapeutics Co., Limited -Company Report
|
February 2008 |
£240 |
Yakult Honsha Co., Ltd. -Company Report
|
February 2008 |
£240 |
Yash Pharma Laboratories Ltd. -Company Report
|
February 2008 |
£240 |
YUNGJIN PHARM. CO.,LTD -Company Report
|
February 2008 |
£240 |
YORK PHARMA PLC -Company Report
|
February 2008 |
£240 |
YASOO Health Inc. -Company Report
|
February 2008 |
£240 |
YOOYOUNG Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Ventria Bioscience -Company Report
|
February 2008 |
£240 |
Vee Excel Drugs & Pharmaceuticals Private Limited -Company Report
|
February 2008 |
£240 |
Tillotts Pharma AG -Company Report
|
February 2008 |
£240 |
Toa Eiyo Ltd. -Company Report
|
February 2008 |
£240 |
TolerRx, Inc. -Company Report
|
February 2008 |
£240 |
Tillomed Laboratories Ltd. -Company Report
|
February 2008 |
£240 |
Tikvah Therapeutics, Inc. -Company Report
|
February 2008 |
£240 |
Tianjin Pharmaceuticals Group Co., Ltd. -Company Report
|
February 2008 |
£240 |
Tibotec BVBA -Company Report
|
February 2008 |
£240 |
Tigris Pharmaceuticals, Inc -Company Report
|
February 2008 |
£240 |
Topotarget A/S -Company Report
|
February 2008 |
£240 |
Toray Industries, Inc. -Company Report
|
February 2008 |
£240 |
TransPharma Medical Ltd. -Company Report
|
February 2008 |
£240 |
TransTech Pharma, Inc. -Company Report
|
February 2008 |
£240 |
Transgene Biotek Ltd. -Company Report
|
February 2008 |
£240 |
TransMolecular, Inc. -Company Report
|
February 2008 |
£240 |
TransGenex Nanobiotech, Inc. -Company Report
|
February 2008 |
£240 |
Torii Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Torrent Pharmaceuticals Limited -Company Report
|
February 2008 |
£240 |
Thrombotargets Corporation -Company Report
|
February 2008 |
£240 |
ThromboGenics NV -Company Report
|
February 2008 |
£240 |
Teikoku Pharma USA, Inc. -Company Report
|
February 2008 |
£240 |
Teikoku Seiyaku Co., Ltd. -Company Report
|
February 2008 |
£240 |
Tekmira Pharmaceuticals Corporation -Company Report
|
February 2008 |
£240 |
Teijin Pharma Limited -Company Report
|
February 2008 |
£240 |
Tehran Chemie Pharmaceutical Co. -Company Report
|
February 2008 |
£240 |
Targepeutics, Inc. -Company Report
|
February 2008 |
£240 |
Taxolog, Inc. -Company Report
|
February 2008 |
£240 |
Telluride Pharmaceutical Corporation -Company Report
|
February 2008 |
£240 |
Temmler Pharma GmbH & Co. KG -Company Report
|
February 2008 |
£240 |
Theratechnologies, Inc. -Company Report
|
February 2008 |
£240 |
Therion Biologics Corporation -Company Report
|
February 2008 |
£240 |
Three Rivers Pharmaceuticals -Company Report
|
February 2008 |
£240 |
Theracos, Inc. -Company Report
|
February 2008 |
£240 |
TheraQuest Biosciences -Company Report
|
February 2008 |
£240 |
Teva Neuroscience -Company Report
|
February 2008 |
£240 |
Thallion Pharmaceuticals Inc. -Company Report
|
February 2008 |
£240 |
Transgene S.A. -Company Report
|
February 2008 |
£240 |
Tranzyme Pharma Inc. -Company Report
|
February 2008 |
£240 |
United Research Laboratories and Mutual Pharmaceutical Company -Company Report
|
February 2008 |
£240 |
Upsher -Smith Laboratories, Inc. -Company Report
|
February 2008 |
£240 |
VGX Pharmaceuticals, Inc -Company Report
|
February 2008 |
£240 |
United Douglas Pharm. Inc. -Company Report
|
February 2008 |
£240 |
Unison Laboratories Co., Ltd -Company Report
|
February 2008 |
£240 |
Unimarck Healthcare Limited. (UHL) -Company Report
|
February 2008 |
£240 |
Unipharm Ltd. -Company Report
|
February 2008 |
£240 |
VHB Life Sciences Inc. -Company Report
|
February 2008 |
£240 |
VINS Bioproducts Ltd. -Company Report
|
February 2008 |
£240 |
Vaxon Biotech -Company Report
|
February 2008 |
£240 |
Vectorite Biomedica, Inc. -Company Report
|
February 2008 |
£240 |
Vectura Group plc. -Company Report
|
February 2008 |
£240 |
VasGene Therapeutics, Inc. -Company Report
|
February 2008 |
£240 |
Vanguard Therapeutics (P) Limited. -Company Report
|
February 2008 |
£240 |
VM Discovery, Inc. -Company Report
|
February 2008 |
£240 |
Vaccinex, Inc. -Company Report
|
February 2008 |
£240 |
Unicure Remedies Pvt. Ltd. -Company Report
|
February 2008 |
£240 |
Unichem Laboratories Ltd. -Company Report
|
February 2008 |
£240 |
Troikaa Pharmaceuticals Ltd. -Company Report
|
February 2008 |
£240 |
Trophos SA -Company Report
|
February 2008 |
£240 |
Twilight Litaka Pharma Ltd. -Company Report
|
February 2008 |
£240 |
Trillium Therapeutics Inc. -Company Report
|
February 2008 |
£240 |
Trigen Holdings AG -Company Report
|
February 2008 |
£240 |
Tri -Med -Company Report
|
February 2008 |
£240 |
Triax Pharmaceuticals, LLC. -Company Report
|
February 2008 |
£240 |
Tzamal Medical Group Ltd -Company Report
|
February 2008 |
£240 |
U3 Pharma AG -Company Report
|
February 2008 |
£240 |
USV Limited -Company Report
|
February 2008 |
£240 |
Ulysses Pharmaceuticals -Company Report
|
February 2008 |
£240 |
Unibioscreen SA -Company Report
|
February 2008 |
£240 |
UMN Pharma Inc. -Company Report
|
February 2008 |
£240 |
UDL Laboratories, Inc. -Company Report
|
February 2008 |
£240 |
UCB S.A. -Company Report
|
February 2008 |
£240 |
t2cure GmbH -Company Report
|
February 2008 |
£240 |
Rekah Pharmaceutical Industry Ltd. -Company Report
|
February 2008 |
£240 |
Regulon, Inc -Company Report
|
February 2008 |
£240 |
IL -YANG PHARM. -Company Report
|
February 2008 |
£240 |
INTRACEL Corp -Company Report
|
February 2008 |
£240 |
IRX Therapeutics, Inc. -Company Report
|
February 2008 |
£240 |
IDEA AG -Company Report
|
February 2008 |
£240 |
IBSA Institut Biochimique SA -Company Report
|
February 2008 |
£240 |
Hutchison MediPharma Ltd. -Company Report
|
February 2008 |
£240 |
Hyperion Therapeutics, Inc. -Company Report
|
February 2008 |
£240 |
Hyundai Pharmaceutical -Company Report
|
February 2008 |
£240 |
ISU ABXIS Inc. (formerly PetaGen) -Company Report
|
February 2008 |
£240 |
ImQuest Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Incitive Ltd -Company Report
|
February 2008 |
£240 |
Ind -Swift Limited -Company Report
|
February 2008 |
£240 |
Indchemie Health Specialities Pvt. Ltd -Company Report
|
February 2008 |
£240 |
Immutep S.A. -Company Report
|
February 2008 |
£240 |
Immunotope, Inc. -Company Report
|
February 2008 |
£240 |
Immunitor Corporation Co., Ltd. -Company Report
|
February 2008 |
£240 |
Immunotec Inc. -Company Report
|
February 2008 |
£240 |
Hunter -Fleming Ltd -Company Report
|
February 2008 |
£240 |
Humanetics Corporation -Company Report
|
February 2008 |
£240 |
Heidelberg Pharma AG -Company Report
|
February 2008 |
£240 |
Helix BioPharma Corp. -Company Report
|
February 2008 |
£240 |
Help Pharmaceuticals SA -Company Report
|
February 2008 |
£240 |
Healthpoint, Ltd. -Company Report
|
February 2008 |
£240 |
Healthcare Manufacturing Group -Company Report
|
February 2008 |
£240 |
Hayashibara Co., Ltd. -Company Report
|
February 2008 |
£240 |
Hayat Pharmaceutical Industries (HPI) -Company Report
|
February 2008 |
£240 |
Henan Topfond Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Hermal -Company Report
|
February 2008 |
£240 |
Hisamitsu Pharmaceutical Co., Inc. -Company Report
|
February 2008 |
£240 |
Hoe Pharmaceuticals Sdn. Bhd. -Company Report
|
February 2008 |
£240 |
Hovid Bhd -Company Report
|
February 2008 |
£240 |
Hill Dermaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Hikma Pharmaceuticals PLC -Company Report
|
February 2008 |
£240 |
Hetero drugs Ltd. -Company Report
|
February 2008 |
£240 |
Highnoon Laboratories Ltd. -Company Report
|
February 2008 |
£240 |
Indena S.p.A. -Company Report
|
February 2008 |
£240 |
Indigene Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Isotechnika Inc. -Company Report
|
February 2008 |
£240 |
Italfarmaco S.p.A -Company Report
|
February 2008 |
£240 |
Ito Life Sciences Inc. -Company Report
|
February 2008 |
£240 |
Ipsen Ltd -Company Report
|
February 2008 |
£240 |
Ipsat Therapies Oy -Company Report
|
February 2008 |
£240 |
Inviragen, Inc. -Company Report
|
February 2008 |
£240 |
Ipca Laboratories Limited -Company Report
|
February 2008 |
£240 |
J.B.CHEMICALS & PHARMACEUTICALS LIMITED -Company Report
|
February 2008 |
£240 |
JCR Pharmaceuticals Co., Ltd -Company Report
|
February 2008 |
£240 |
Janssen Pharmaceutica N V -Company Report
|
February 2008 |
£240 |
Janus Pharmaceuticals Inc -Company Report
|
February 2008 |
£240 |
Japan Tobacco Inc. -Company Report
|
February 2008 |
£240 |
Janssen -Cilag S.p.A. -Company Report
|
February 2008 |
£240 |
Jagsonpal Pharmaceuticals Limited -Company Report
|
February 2008 |
£240 |
JSC Farmak International -Company Report
|
February 2008 |
£240 |
JSJ Pharmaceuticals -Company Report
|
February 2008 |
£240 |
Intranasal Therapeutics, Inc (formerly Intranasal Technology, Inc.) -Company Report
|
February 2008 |
£240 |
Intradigm Corporation -Company Report
|
February 2008 |
£240 |
Innocoll Inc. -Company Report
|
February 2008 |
£240 |
Innodia Inc. -Company Report
|
February 2008 |
£240 |
Innogenetics -Company Report
|
February 2008 |
£240 |
Innate Pharma S.A. -Company Report
|
February 2008 |
£240 |
Inimex Pharmaceuticals Inc. -Company Report
|
February 2008 |
£240 |
Indoco Remedies Limited -Company Report
|
February 2008 |
£240 |
Inflabloc Pharmaceuticals, Inc. (formerly Pharmadigm, Inc) -Company Report
|
February 2008 |
£240 |
Inotek Pharmaceuticals, Inc -Company Report
|
February 2008 |
£240 |
Intarcia Therapeutics, Inc. -Company Report
|
February 2008 |
£240 |
Intercytex -Company Report
|
February 2008 |
£240 |
Intra -Cellular Therapies, Inc. (ITI) -Company Report
|
February 2008 |
£240 |
Intra Labs -Company Report
|
February 2008 |
£240 |
Intercept Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Intercell AG -Company Report
|
February 2008 |
£240 |
Intas Pharmaceuticals Ltd. -Company Report
|
February 2008 |
£240 |
Intendis GmBH -Company Report
|
February 2008 |
£240 |
Hawthorn Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Hawon Pharmaceutical Corporation -Company Report
|
February 2008 |
£240 |
Gary Pharmaceuticals P Limited -Company Report
|
February 2008 |
£240 |
Gastrotech Pharma A/S -Company Report
|
February 2008 |
£240 |
Geistlich -Company Report
|
February 2008 |
£240 |
Galenica s.a. -Company Report
|
February 2008 |
£240 |
Galenica Ltd. -Company Report
|
February 2008 |
£240 |
Gaco Pharmaceuticals. -Company Report
|
February 2008 |
£240 |
Gador S.A. -Company Report
|
February 2008 |
£240 |
Galderma Canada, Inc -Company Report
|
February 2008 |
£240 |
Gemin X Biotechnologies Inc. -Company Report
|
February 2008 |
£240 |
GenPhar, Inc. -Company Report
|
February 2008 |
£240 |
General Pharmaceuticals Ltd. -Company Report
|
February 2008 |
£240 |
Generics [UK] Limited -Company Report
|
February 2008 |
£240 |
Genesis Research & Development Corporation Limited -Company Report
|
February 2008 |
£240 |
GeneraMedix Inc. -Company Report
|
February 2008 |
£240 |
Genepharm Australasia Limited -Company Report
|
February 2008 |
£240 |
Gene Signal International SA -Company Report
|
February 2008 |
£240 |
GeneScience Pharmaceuticals Co., Ltd -Company Report
|
February 2008 |
£240 |
GRUPO URIACH -Company Report
|
February 2008 |
£240 |
GRAMON Laboratories -Company Report
|
February 2008 |
£240 |
Fresenius Kabi AG -Company Report
|
February 2008 |
£240 |
Fujimoto Pharmaceutical Corp -Company Report
|
February 2008 |
£240 |
Fulford (India) Limited -Company Report
|
February 2008 |
£240 |
Fresenius AG -Company Report
|
February 2008 |
£240 |
Fovea Pharmaceuticals SA -Company Report
|
February 2008 |
£240 |
Flynn Pharma Ltd -Company Report
|
February 2008 |
£240 |
Foamix Ltd -Company Report
|
February 2008 |
£240 |
Futura Medical plc -Company Report
|
February 2008 |
£240 |
G & W Laboratories, Inc. -Company Report
|
February 2008 |
£240 |
GLYCOTOPE GmbH -Company Report
|
February 2008 |
£240 |
GNI Ltd. -Company Report
|
February 2008 |
£240 |
GP Pharm -Company Report
|
February 2008 |
£240 |
GEYMONAT S.p.A. -Company Report
|
February 2008 |
£240 |
GENESIS Pharma SA -Company Report
|
February 2008 |
£240 |
GALDERMA INTERNATIONAL SAS -Company Report
|
February 2008 |
£240 |
GATE Pharmaceuticals -Company Report
|
February 2008 |
£240 |
Genetix Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Genextra S.p.A. -Company Report
|
February 2008 |
£240 |
Green Cross Corporation -Company Report
|
February 2008 |
£240 |
Grifols, S.A. -Company Report
|
February 2008 |
£240 |
Grindeks -Company Report
|
February 2008 |
£240 |
Graceway Pharmaceuticals, LLC -Company Report
|
February 2008 |
£240 |
Goldshield Group plc -Company Report
|
February 2008 |
£240 |
Gloucester Pharmaceuticals -Company Report
|
February 2008 |
£240 |
GlycoMimetics, Inc. -Company Report
|
February 2008 |
£240 |
Grunenthal GmbH -Company Report
|
February 2008 |
£240 |
Grupo Ferrer -Company Report
|
February 2008 |
£240 |
Handok Pharmaceuticals Co., Ltd. -Company Report
|
February 2008 |
£240 |
Hanmi Pharmaceutical Company Limited -Company Report
|
February 2008 |
£240 |
Hau Giang Pharmaceutical (HG.PHARM) -Company Report
|
February 2008 |
£240 |
HanAll Pharmaceutical -Company Report
|
February 2008 |
£240 |
Hamilton Laboratories -Company Report
|
February 2008 |
£240 |
HELSINN HEALTHCARE SA -Company Report
|
February 2008 |
£240 |
HOMEOFARM Sp. z o.o. -Company Report
|
February 2008 |
£240 |
GlobeImmune, Inc. -Company Report
|
February 2008 |
£240 |
Glenwood, LLC -Company Report
|
February 2008 |
£240 |
Genpat77 Pharmacogenetics AG -Company Report
|
February 2008 |
£240 |
Genx Pharma Ltd. -Company Report
|
February 2008 |
£240 |
Georen Pharmaceuticals (Pty) Ltd. -Company Report
|
February 2008 |
£240 |
Genovate Biotechnology Co., Ltd. (GBL) -Company Report
|
February 2008 |
£240 |
Geno Pharmaceuticals Ltd. -Company Report
|
February 2008 |
£240 |
Genfit -Company Report
|
February 2008 |
£240 |
Genmab A/S -Company Report
|
February 2008 |
£240 |
Germiphene Corporation -Company Report
|
February 2008 |
£240 |
Gerolymatos -Company Report
|
February 2008 |
£240 |
Glades Pharmaceuticals LLC. -Company Report
|
February 2008 |
£240 |
Gland Pharma Limited -Company Report
|
February 2008 |
£240 |
Glenmark Pharmaceuticals Limited -Company Report
|
February 2008 |
£240 |
Giuliani S.p.A -Company Report
|
February 2008 |
£240 |
Giaconda Limited -Company Report
|
February 2008 |
£240 |
Gerot Pharmazeutika -Company Report
|
February 2008 |
£240 |
Getwell Life Sciences -Company Report
|
February 2008 |
£240 |
Jeil Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Jelfa Pharmaceutical Company SA -Company Report
|
February 2008 |
£240 |
Presidio Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Prestwick Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Pro Vaccine AG -Company Report
|
February 2008 |
£240 |
PregLem SA -Company Report
|
February 2008 |
£240 |
PT. Pyridam Farma Tbk -Company Report
|
February 2008 |
£240 |
PT Bernofarm -Company Report
|
February 2008 |
£240 |
PT Kalbe Farma Tbk. -Company Report
|
February 2008 |
£240 |
PT Kimia Farma Tbk -Company Report
|
February 2008 |
£240 |
ProEthic Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
ProMetic Life Sciences Inc. -Company Report
|
February 2008 |
£240 |
Prometheus Laboratories, Inc. -Company Report
|
February 2008 |
£240 |
PronovaMedical B.V. -Company Report
|
February 2008 |
£240 |
Proper Nutrition, Inc. -Company Report
|
February 2008 |
£240 |
Prolysis Limited -Company Report
|
February 2008 |
£240 |
Prolexys Pharmaceuticals, Inc -Company Report
|
February 2008 |
£240 |
ProStrakan Group plc -Company Report
|
February 2008 |
£240 |
Procaps SA -Company Report
|
February 2008 |
£240 |
Lee''s Pharmaceutical Holdings Ltd -Company Report
|
February 2008 |
£240 |
kucera pharmaceuticals -Company Report
|
February 2008 |
£240 |
Lee''s Pharmaceutical Holdings Ltd -Company Report
|
February 2008 |
£240 |
LeukoMed, Inc. -Company Report
|
February 2008 |
£240 |
LiPlasome Pharma A/S -Company Report
|
February 2008 |
£240 |
Lay Line Genomics SpA -Company Report
|
February 2008 |
£240 |
Lawley Pharmaceuticals -Company Report
|
February 2008 |
£240 |
Lannacher Heilmittel Gmbh -Company Report
|
February 2008 |
£240 |
Lark Laboratories -Company Report
|
February 2008 |
£240 |
LifeCycle Pharma -Company Report
|
February 2008 |
£240 |
LifeTec Group Limited -Company Report
|
February 2008 |
£240 |
Lipomed AG -Company Report
|
February 2008 |
£240 |
Lipoxen -Company Report
|
February 2008 |
£240 |
hameln pharmaceuticals gmbh -Company Report
|
February 2008 |
£240 |
Lipocine Inc. -Company Report
|
February 2008 |
£240 |
Lipicard Technologies Limited -Company Report
|
February 2008 |
£240 |
LigoCyte Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Lion Corporation -Company Report
|
February 2008 |
£240 |
Protein Sciences Corporation -Company Report
|
February 2008 |
£240 |
Protemix Corporation Limited -Company Report
|
February 2008 |
£240 |
Radiant Medical, Inc -Company Report
|
February 2008 |
£240 |
Radius (formerly NuVios, Inc.) -Company Report
|
February 2008 |
£240 |
Rafa Laboratories, Ltd. -Company Report
|
February 2008 |
£240 |
Raazee Therapeutics (Pvt) Ltd. -Company Report
|
February 2008 |
£240 |
RPG Life Sciences Ltd. -Company Report
|
February 2008 |
£240 |
ROHTO Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
ROWA Pharmaceuticals Ltd. -Company Report
|
February 2008 |
£240 |
Ranbaxy Laboratories Ltd. -Company Report
|
February 2008 |
£240 |
Rare Disease Therapeutics, Inc. -Company Report
|
February 2008 |
£240 |
Receptor BioLogix, Inc. -Company Report
|
February 2008 |
£240 |
Reckitt Benckiser Group plc. -Company Report
|
February 2008 |
£240 |
Redox Pharmaceutical Corporation -Company Report
|
February 2008 |
£240 |
ReceptoPharm, Inc -Company Report
|
February 2008 |
£240 |
Reata Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Raven biotechnologies, inc. -Company Report
|
February 2008 |
£240 |
ReNeuron Group plc -Company Report
|
February 2008 |
£240 |
RFS Pharma, LLC -Company Report
|
February 2008 |
£240 |
RFE Pharma Corp -Company Report
|
February 2008 |
£240 |
Purdue Pharma L.P -Company Report
|
February 2008 |
£240 |
Purzer Pharmaceutical Co. Ltd. -Company Report
|
February 2008 |
£240 |
Q -Med AB -Company Report
|
February 2008 |
£240 |
Provalis plc -Company Report
|
February 2008 |
£240 |
Protox Therapeutics Inc. -Company Report
|
February 2008 |
£240 |
Proteolix -Company Report
|
February 2008 |
£240 |
Protiva Biotherapeutics Inc -Company Report
|
February 2008 |
£240 |
QOL Medical, LLC -Company Report
|
February 2008 |
£240 |
QRxPharma Pty Ltd -Company Report
|
February 2008 |
£240 |
RECORDATI SpA -Company Report
|
February 2008 |
£240 |
REPLICor Inc. -Company Report
|
February 2008 |
£240 |
REVOTAR Biopharmaceuticals AG -Company Report
|
February 2008 |
£240 |
RAFARM S.A. -Company Report
|
February 2008 |
£240 |
Quest PharmaTech Inc. (formerly Altachem Pharma Ltd.) -Company Report
|
February 2008 |
£240 |
Quark Pharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
QuatRx Pharmaceuticals -Company Report
|
February 2008 |
£240 |
Laboratorios Salvat, S.A -Company Report
|
February 2008 |
£240 |
Laboratorios Phoenix -Company Report
|
February 2008 |
£240 |
Kee Pharma Ltd. -Company Report
|
February 2008 |
£240 |
Kemia, Inc -Company Report
|
February 2008 |
£240 |
Kemin Industries, Inc. -Company Report
|
February 2008 |
£240 |
Karo Bio AB -Company Report
|
February 2008 |
£240 |
Kamron Laboratories Ltd. -Company Report
|
February 2008 |
£240 |
Kaire International (Canada) Ltd -Company Report
|
February 2008 |
£240 |
Kalypsys, Inc. -Company Report
|
February 2008 |
£240 |
Kamada Ltd. -Company Report
|
February 2008 |
£240 |
Kenta Biotech Ltd. -Company Report
|
February 2008 |
£240 |
KeyNeurotek AG -Company Report
|
February 2008 |
£240 |
Kinex Pharmaceuticals, LLC -Company Report
|
February 2008 |
£240 |
Kirin Pharma Company Limited -Company Report
|
February 2008 |
£240 |
Kissei Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Kilitch Drugs (I) Ltd. -Company Report
|
February 2008 |
£240 |
Kiel Laboratories -Company Report
|
February 2008 |
£240 |
Khandelwal Laboratories Pvt. Limited -Company Report
|
February 2008 |
£240 |
Kiadis Pharma B.V. -Company Report
|
February 2008 |
£240 |
KUREHA CORPORATION (formerly Kureha Chemical Industry Co., Ltd.) -Company Report
|
February 2008 |
£240 |
KUKJE PHARMA IND CO LTD -Company Report
|
February 2008 |
£240 |
Jiangsu Chia -tai Tianqing Pharmaceutical Co. Ltd -Company Report
|
February 2008 |
£240 |
Jiangsu Lianhuan Pharmaceutical Co., Ltd -Company Report
|
February 2008 |
£240 |
Jiangsu Lianshui Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Jerini AG -Company Report
|
February 2008 |
£240 |
Jennerex Biotherapeutics, Inc. -Company Report
|
February 2008 |
£240 |
Jemo -pharm A/S -Company Report
|
February 2008 |
£240 |
Jenburkt Pharmaceuticals Ltd. -Company Report
|
February 2008 |
£240 |
Jin Yang Pharmaceutical Co. Ltd -Company Report
|
February 2008 |
£240 |
Jiwa Bio -Pharm Holdings Limited -Company Report
|
February 2008 |
£240 |
KAKETSUKEN -Company Report
|
February 2008 |
£240 |
KARNATAKA ANTIBIOTICS AND PHARMACEUTICALS LIMITED -Company Report
|
February 2008 |
£240 |
KOBEC Pharmacals -Company Report
|
February 2008 |
£240 |
KAKEN PHARMACEUTICAL CO., LTD. -Company Report
|
February 2008 |
£240 |
KAI Pharmaceuticals Inc. -Company Report
|
February 2008 |
£240 |
Julphar -Company Report
|
February 2008 |
£240 |
Juste S.A.Q.F. -Company Report
|
February 2008 |
£240 |
Kobayashi Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Kontest Chemicals Limited -Company Report
|
February 2008 |
£240 |
Laborate Pharmaceuticals India Ltd -Company Report
|
February 2008 |
£240 |
Laboratoire HRA Pharma -Company Report
|
February 2008 |
£240 |
Laboratoire Innotech International -Company Report
|
February 2008 |
£240 |
LaborMed Pharma -Company Report
|
February 2008 |
£240 |
LIBBS Farmaceutica Ltd -Company Report
|
February 2008 |
£240 |
LEO Pharma A/S -Company Report
|
February 2008 |
£240 |
LG Life Sciences Ltd. -Company Report
|
February 2008 |
£240 |
Laboratoires SMB SA -Company Report
|
February 2008 |
£240 |
Laboratoires Thea -Company Report
|
February 2008 |
£240 |
Laboratorios Almirall, S.A. -Company Report
|
February 2008 |
£240 |
Laboratorios Gebro Pharma, S.A. -Company Report
|
February 2008 |
£240 |
Laboratorios Juventus, S.A. -Company Report
|
February 2008 |
£240 |
Laboratorio Teuto -Company Report
|
February 2008 |
£240 |
Laboratorio Elea SACIFYA -Company Report
|
February 2008 |
£240 |
Laboratori Guidotti SpA -Company Report
|
February 2008 |
£240 |
Laboratorio EDOL Produtos Farmaceuticos, S.A. -Company Report
|
February 2008 |
£240 |
LAVIPHARM Group -Company Report
|
February 2008 |
£240 |
LACER, S.A. -Company Report
|
February 2008 |
£240 |
Krka, d. d. -Company Report
|
February 2008 |
£240 |
Kuhnil Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
KunWha Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Kringle Pharma, Inc. -Company Report
|
February 2008 |
£240 |
Krenitsky Pharmaceuticals Inc. -Company Report
|
February 2008 |
£240 |
Kopran Ltd. -Company Report
|
February 2008 |
£240 |
Kowa Company, Ltd. -Company Report
|
February 2008 |
£240 |
Kwang -Dong Pharmaceutical Co., Ltd -Company Report
|
February 2008 |
£240 |
Kyorin Co., Ltd. -Company Report
|
February 2008 |
£240 |
Kythera Biopharmaceuticals, Inc. -Company Report
|
February 2008 |
£240 |
Kyung Dong Pharma. Co., Ltd. -Company Report
|
February 2008 |
£240 |
LABORATORIOS FARMACEUTICOS ROVI, S.A -Company Report
|
February 2008 |
£240 |
Kyowa Pharmaceutical, Inc -Company Report
|
February 2008 |
£240 |
Kyowa Hakko Kogyo Co., Ltd. -Company Report
|
February 2008 |
£240 |
Kyosei Pharmaceutical Co., Ltd. -Company Report
|
February 2008 |
£240 |
Kyoto Pharmaceutical Industries -Company Report
|
February 2008 |
£240 |
Dynatronics Corporation -Financial Company Report
|
February 2008 |
£110 |
Dynacq Healthcare Inc -Financial Company Report
|
February 2008 |
£110 |
Novozymes A -Financial Company Report
|
February 2008 |
£110 |
Nu Skin Enterprises Inc. -Financial Company Report
|
February 2008 |
£110 |
NuVasive Inc -Financial Company Report
|
February 2008 |
£110 |
Novogen Ltd -Financial Company Report
|
February 2008 |
£110 |
Novo -Nordisk A -Financial Company Report
|
February 2008 |
£110 |
Novavax Inc -Financial Company Report
|
February 2008 |
£110 |
Novelos Therapeutics Inc -Financial Company Report
|
February 2008 |
£110 |
Noven Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Nucryst Pharmaceuticals Corp -Financial Company Report
|
February 2008 |
£110 |
Nutra Pharma Corp -Financial Company Report
|
February 2008 |
£110 |
Nventa Biopharmaceuticals Corp -Financial Company Report
|
February 2008 |
£110 |
Nxstage Medical Inc -Financial Company Report
|
February 2008 |
£110 |
Nyer Medical Group Inc -Financial Company Report
|
February 2008 |
£110 |
Nuvelo Inc. -Financial Company Report
|
February 2008 |
£110 |
Nutrition 21 Inc -Financial Company Report
|
February 2008 |
£110 |
NutraCea -Financial Company Report
|
February 2008 |
£110 |
Nutraceutical International Corporation -Financial Company Report
|
February 2008 |
£110 |
Novartis AG -Financial Company Report
|
February 2008 |
£110 |
Novadel Pharma Inc -Financial Company Report
|
February 2008 |
£110 |
NewMarket Corp -Financial Company Report
|
February 2008 |
£110 |
NexMed Inc -Financial Company Report
|
February 2008 |
£110 |
NightHawk Radiology Holdings, Inc. -Financial Company Report
|
February 2008 |
£110 |
New Life Scientific Inc. -Financial Company Report
|
February 2008 |
£110 |
New American Healthcare Corp. -Financial Company Report
|
February 2008 |
£110 |
Neurologix Inc -Financial Company Report
|
February 2008 |
£110 |
Nevada Chemicals Inc -Financial Company Report
|
February 2008 |
£110 |
Nile Therapeutics, Inc -Financial Company Report
|
February 2008 |
£110 |
Nitromed Inc -Financial Company Report
|
February 2008 |
£110 |
Northwest Biotherapeutics Inc -Financial Company Report
|
February 2008 |
£110 |
NovaMed Inc -Financial Company Report
|
February 2008 |
£110 |
Novacea Inc -Financial Company Report
|
February 2008 |
£110 |
Northstar Neuroscience Inc -Financial Company Report
|
February 2008 |
£110 |
Northfield Laboratories Inc -Financial Company Report
|
February 2008 |
£110 |
Non -Invasive Monitoring Systems Inc -Financial Company Report
|
February 2008 |
£110 |
North American Scientific Inc -Financial Company Report
|
February 2008 |
£110 |
Nymox Pharmaceutical Corporation -Financial Company Report
|
February 2008 |
£110 |
OI Corporation -Financial Company Report
|
February 2008 |
£110 |
Optigenex Inc. -Financial Company Report
|
February 2008 |
£110 |
Optimer Pharmaceuticals, Inc. -Financial Company Report
|
February 2008 |
£110 |
OptimumCare Corporation -Financial Company Report
|
February 2008 |
£110 |
Opko Health, Inc. -Financial Company Report
|
February 2008 |
£110 |
Ophthalmic Imaging Systems Inc -Financial Company Report
|
February 2008 |
£110 |
Onyx Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Opexa Therapeutics Inc -Financial Company Report
|
February 2008 |
£110 |
OraSure Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Oragenics Inc -Financial Company Report
|
February 2008 |
£110 |
Ore Pharmaceuticals Inc. -Financial Company Report
|
February 2008 |
£110 |
Orexigen Therapeutics, Inc. -Financial Company Report
|
February 2008 |
£110 |
Organic Recycling Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Orchid Chemicals & Pharmaceuticals Ltd -Financial Company Report
|
February 2008 |
£110 |
Orchid Cellmark Inc -Financial Company Report
|
February 2008 |
£110 |
Oramed Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Orchestra Therapeutics, Inc. -Financial Company Report
|
February 2008 |
£110 |
Ondine Biopharma Corp -Financial Company Report
|
February 2008 |
£110 |
Oncothyreon, Inc. -Financial Company Report
|
February 2008 |
£110 |
OXiGENE INC -Financial Company Report
|
February 2008 |
£110 |
Obagi Medical Products Inc -Financial Company Report
|
February 2008 |
£110 |
OccuLogix Inc -Financial Company Report
|
February 2008 |
£110 |
OXIS International Inc -Financial Company Report
|
February 2008 |
£110 |
OSI Systems, Inc. -Financial Company Report
|
February 2008 |
£110 |
OM Group Inc -Financial Company Report
|
February 2008 |
£110 |
OSI Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Oculus Innovative Sciences Inc -Financial Company Report
|
February 2008 |
£110 |
Odyssey Healthcare Inc -Financial Company Report
|
February 2008 |
£110 |
Omrix Biopharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
OncoVista, Inc. -Financial Company Report
|
February 2008 |
£110 |
Oncolytics Biotech Inc -Financial Company Report
|
February 2008 |
£110 |
Omnicare Inc. -Financial Company Report
|
February 2008 |
£110 |
OmniComm Systems Inc. -Financial Company Report
|
February 2008 |
£110 |
Oil -Dri Corporation Of America -Financial Company Report
|
February 2008 |
£110 |
Omni Nutraceuticals, Inc. -Financial Company Report
|
February 2008 |
£110 |
NeurogesX, Inc. -Financial Company Report
|
February 2008 |
£110 |
Neurogenesis Inc -Financial Company Report
|
February 2008 |
£110 |
Miracor Diagnostics Inc -Financial Company Report
|
February 2008 |
£110 |
Miravant Medical Technologies -Financial Company Report
|
February 2008 |
£110 |
Misonix Inc -Financial Company Report
|
February 2008 |
£110 |
Minerals Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Mindray Medical International Ltd. -Financial Company Report
|
February 2008 |
£110 |
Millennium Biotechnologies Group Inc -Financial Company Report
|
February 2008 |
£110 |
Millennium Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Millipore Corporation -Financial Company Report
|
February 2008 |
£110 |
Modern Medical Modalities Corp -Financial Company Report
|
February 2008 |
£110 |
Modigene, Inc. -Financial Company Report
|
February 2008 |
£110 |
Monsanto Company -Financial Company Report
|
February 2008 |
£110 |
MultiCell Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Mylan, Inc. -Financial Company Report
|
February 2008 |
£110 |
Monogram Biosciences Inc -Financial Company Report
|
February 2008 |
£110 |
Momenta Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Molecular Insight Pharmaceuticals, Inc. -Financial Company Report
|
February 2008 |
£110 |
Molina Healthcare Inc -Financial Company Report
|
February 2008 |
£110 |
Millenia Hope Inc -Financial Company Report
|
February 2008 |
£110 |
Milestone Scientific Inc -Financial Company Report
|
February 2008 |
£110 |
Metabolix, Inc. -Financial Company Report
|
February 2008 |
£110 |
MethylGene Inc -Financial Company Report
|
February 2008 |
£110 |
Metropolitan Health Networks Inc -Financial Company Report
|
February 2008 |
£110 |
Metabolic Research, Inc. -Financial Company Report
|
February 2008 |
£110 |
Metabolic Pharmaceuticals Ltd. -Financial Company Report
|
February 2008 |
£110 |
Mesa Laboratories Inc -Financial Company Report
|
February 2008 |
£110 |
Metabasis Therapeutics Inc -Financial Company Report
|
February 2008 |
£110 |
Mettler -Toledo International Inc. -Financial Company Report
|
February 2008 |
£110 |
Micro Laboratories Inc -Financial Company Report
|
February 2008 |
£110 |
Mid -Atlantic Home Health Network -Financial Company Report
|
February 2008 |
£110 |
MiddleBrook Pharmaceuticals, Inc. -Financial Company Report
|
February 2008 |
£110 |
Migenix Inc -Financial Company Report
|
February 2008 |
£110 |
Micrus Endovascular Corp -Financial Company Report
|
February 2008 |
£110 |
Micromet Inc -Financial Company Report
|
February 2008 |
£110 |
MicroIslet, Inc. -Financial Company Report
|
February 2008 |
£110 |
MicroMed Cardiovascular Inc -Financial Company Report
|
February 2008 |
£110 |
Mymetics Corporation -Financial Company Report
|
February 2008 |
£110 |
Myriad Genetics Inc -Financial Company Report
|
February 2008 |
£110 |
Neoprobe Corp -Financial Company Report
|
February 2008 |
£110 |
Neose Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Neostem Inc -Financial Company Report
|
February 2008 |
£110 |
Neogen Corporation -Financial Company Report
|
February 2008 |
£110 |
NeoPharm Inc -Financial Company Report
|
February 2008 |
£110 |
Nektar Therapeutics -Financial Company Report
|
February 2008 |
£110 |
NeoGenomics Inc -Financial Company Report
|
February 2008 |
£110 |
Nephros Inc. -Financial Company Report
|
February 2008 |
£110 |
Neptune Technologies & Bioresources, Inc. -Financial Company Report
|
February 2008 |
£110 |
Neurochem Inc -Financial Company Report
|
February 2008 |
£110 |
Neurocrine Biosciences Inc -Financial Company Report
|
February 2008 |
£110 |
Neurogen Corporation -Financial Company Report
|
February 2008 |
£110 |
Neurobiological Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
NeuroMetrix Inc -Financial Company Report
|
February 2008 |
£110 |
Nestle SA -Financial Company Report
|
February 2008 |
£110 |
Neuro -Hitech Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Nature's Sunshine Products Inc -Financial Company Report
|
February 2008 |
£110 |
NatureWell Inc -Financial Company Report
|
February 2008 |
£110 |
Nalco Holding Co -Financial Company Report
|
February 2008 |
£110 |
NanoLogix Inc -Financial Company Report
|
February 2008 |
£110 |
NanoViricides, Inc. -Financial Company Report
|
February 2008 |
£110 |
Nabi Biopharmaceuticals -Financial Company Report
|
February 2008 |
£110 |
NPS Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
NL Industries Inc -Financial Company Report
|
February 2008 |
£110 |
NMT Medical, Inc. -Financial Company Report
|
February 2008 |
£110 |
Nanobac Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Nanogen Inc -Financial Company Report
|
February 2008 |
£110 |
National Quality Care Inc -Financial Company Report
|
February 2008 |
£110 |
Naturade Inc -Financial Company Report
|
February 2008 |
£110 |
Natural Alternatives International Inc -Financial Company Report
|
February 2008 |
£110 |
National Healthcare Corp -Financial Company Report
|
February 2008 |
£110 |
National Dentex Corp -Financial Company Report
|
February 2008 |
£110 |
Nanophase Technologies Corporation -Financial Company Report
|
February 2008 |
£110 |
Nastech Pharmaceutical Co Inc -Financial Company Report
|
February 2008 |
£110 |
Orion HealthCorp Inc -Financial Company Report
|
February 2008 |
£110 |
OrthoLogic Corporation -Financial Company Report
|
February 2008 |
£110 |
Quality Systems Inc -Financial Company Report
|
February 2008 |
£110 |
Quantech Ltd. -Financial Company Report
|
February 2008 |
£110 |
Quest BioTechnology -Financial Company Report
|
February 2008 |
£110 |
Quaker Chemical Corp -Financial Company Report
|
February 2008 |
£110 |
QuadraMed Corp -Financial Company Report
|
February 2008 |
£110 |
QLT Inc -Financial Company Report
|
February 2008 |
£110 |
QMed Inc -Financial Company Report
|
February 2008 |
£110 |
Qiagen N.V -Financial Company Report
|
February 2008 |
£110 |
Questcor Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Quick -Med Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
RainTree Healthcare Corp -Financial Company Report
|
February 2008 |
£110 |
Ramp Corp. -Financial Company Report
|
February 2008 |
£110 |
Raptor Pharmaceuticals Corp. -Financial Company Report
|
February 2008 |
£110 |
Radiation Therapy Services Inc -Financial Company Report
|
February 2008 |
£110 |
RadNet Inc -Financial Company Report
|
February 2008 |
£110 |
Quidel Corporation -Financial Company Report
|
February 2008 |
£110 |
Rad Source Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Pure Bioscience -Financial Company Report
|
February 2008 |
£110 |
Puleva Biotech SA -Financial Company Report
|
February 2008 |
£110 |
Protalex Inc -Financial Company Report
|
February 2008 |
£110 |
Protalix BioTherapeutics, Inc. -Financial Company Report
|
February 2008 |
£110 |
Protein Polymer Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Promedco Management Co. -Financial Company Report
|
February 2008 |
£110 |
Progenics Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Procyon Corp. -Financial Company Report
|
February 2008 |
£110 |
Progen Pharmaceuticals Ltd. -Financial Company Report
|
February 2008 |
£110 |
Proteo Inc -Financial Company Report
|
February 2008 |
£110 |
Proteome Science PLC -Financial Company Report
|
February 2008 |
£110 |
Psivida Ltd -Financial Company Report
|
February 2008 |
£110 |
Psychemedics Corp -Financial Company Report
|
February 2008 |
£110 |
Psychiatric solutions Inc -Financial Company Report
|
February 2008 |
£110 |
Provectus Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
ProtoKinetix Inc -Financial Company Report
|
February 2008 |
£110 |
Protherics PLC -Financial Company Report
|
February 2008 |
£110 |
Protide Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
ReGen Biologics Inc -Financial Company Report
|
February 2008 |
£110 |
Receivable Acquisition and Management Corp. -Financial Company Report
|
February 2008 |
£110 |
Retractable Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Rexahn Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Rhodia SA -Financial Company Report
|
February 2008 |
£110 |
Restore Medical Inc -Financial Company Report
|
February 2008 |
£110 |
Response Oncology, Inc. -Financial Company Report
|
February 2008 |
£110 |
Response Biomedical Corp -Financial Company Report
|
February 2008 |
£110 |
Response Genetics, Inc -Financial Company Report
|
February 2008 |
£110 |
Rigel Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Rite Aid Corporation -Financial Company Report
|
February 2008 |
£110 |
Rockwood Holdings Inc. -Financial Company Report
|
February 2008 |
£110 |
Rohm & Haas Co -Financial Company Report
|
February 2008 |
£110 |
Rosetta Genomics Ltd. -Financial Company Report
|
February 2008 |
£110 |
Rockwell Medical Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Rockport Healthcare Group Inc -Financial Company Report
|
February 2008 |
£110 |
Roche Holdings Ltd -Financial Company Report
|
February 2008 |
£110 |
Rochester Medical Corporation -Financial Company Report
|
February 2008 |
£110 |
Respironics Inc -Financial Company Report
|
February 2008 |
£110 |
ResMed Inc -Financial Company Report
|
February 2008 |
£110 |
Regeneron Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Regent Assisted Living Inc. -Financial Company Report
|
February 2008 |
£110 |
RehabCare Group Inc -Financial Company Report
|
February 2008 |
£110 |
Regeneration Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
RegeneRx Biopharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Redpoint Bio Corporation -Financial Company Report
|
February 2008 |
£110 |
Regen Therapeutics plc -Financial Company Report
|
February 2008 |
£110 |
Reliv International Inc -Financial Company Report
|
February 2008 |
£110 |
Remedent Inc -Financial Company Report
|
February 2008 |
£110 |
Repro -Med Systems Inc -Financial Company Report
|
February 2008 |
£110 |
Repros Therapeutics Inc -Financial Company Report
|
February 2008 |
£110 |
Res -Care Inc -Financial Company Report
|
February 2008 |
£110 |
Repligen Corporation -Financial Company Report
|
February 2008 |
£110 |
Replidyne Inc -Financial Company Report
|
February 2008 |
£110 |
Renovis Inc -Financial Company Report
|
February 2008 |
£110 |
Reparotech, Inc. -Financial Company Report
|
February 2008 |
£110 |
Procter & Gamble Company -Financial Company Report
|
February 2008 |
£110 |
Pro -Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Par Pharmaceutical Companies Inc -Financial Company Report
|
February 2008 |
£110 |
Paradigm Medical Industries Inc -Financial Company Report
|
February 2008 |
£110 |
Patient Safety Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Panacos Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Palomar Medical Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
PainCare Holdings Inc -Financial Company Report
|
February 2008 |
£110 |
Palatin Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Pall Corporation -Financial Company Report
|
February 2008 |
£110 |
Patterson Companies Inc -Financial Company Report
|
February 2008 |
£110 |
Pediatrix Medical Group Inc -Financial Company Report
|
February 2008 |
£110 |
PerkinElmer Inc -Financial Company Report
|
February 2008 |
£110 |
Perrigo Company -Financial Company Report
|
February 2008 |
£110 |
Pfizer Inc -Financial Company Report
|
February 2008 |
£110 |
Peregrine Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Peplin Ltd -Financial Company Report
|
February 2008 |
£110 |
Penford Corporation -Financial Company Report
|
February 2008 |
£110 |
Penwest Pharmaceuticals Co -Financial Company Report
|
February 2008 |
£110 |
Pain Therapeutics Inc -Financial Company Report
|
February 2008 |
£110 |
PacificHealth Laboratories Inc -Financial Company Report
|
February 2008 |
£110 |
Osteologix, Inc. -Financial Company Report
|
February 2008 |
£110 |
Osteotech Inc -Financial Company Report
|
February 2008 |
£110 |
PAREXEL International Corp -Financial Company Report
|
February 2008 |
£110 |
Osiris Therapeutics Inc -Financial Company Report
|
February 2008 |
£110 |
Oscient Pharmaceuticals Corp -Financial Company Report
|
February 2008 |
£110 |
Orthofix International N V -Financial Company Report
|
February 2008 |
£110 |
Orthometrix Inc -Financial Company Report
|
February 2008 |
£110 |
PDL BioPharma Inc -Financial Company Report
|
February 2008 |
£110 |
PHC Inc -Financial Company Report
|
February 2008 |
£110 |
PTS Inc -Financial Company Report
|
February 2008 |
£110 |
Pace Medical Inc -Financial Company Report
|
February 2008 |
£110 |
Pacific Biometrics Inc. -Financial Company Report
|
February 2008 |
£110 |
PSS World Medical Inc. -Financial Company Report
|
February 2008 |
£110 |
PPG Industries Inc -Financial Company Report
|
February 2008 |
£110 |
PLC Systems Inc -Financial Company Report
|
February 2008 |
£110 |
POZEN Inc -Financial Company Report
|
February 2008 |
£110 |
PharMerica Corporation -Financial Company Report
|
February 2008 |
£110 |
PharmChem Inc -Financial Company Report
|
February 2008 |
£110 |
Poniard Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Positron Corporation -Financial Company Report
|
February 2008 |
£110 |
Possis Medical Inc -Financial Company Report
|
February 2008 |
£110 |
Polydex Pharmaceuticals Ltd -Financial Company Report
|
February 2008 |
£110 |
PolyMedix Inc -Financial Company Report
|
February 2008 |
£110 |
Pluristem Therapeutics, Inc. -Financial Company Report
|
February 2008 |
£110 |
Point Therapeutics Inc -Financial Company Report
|
February 2008 |
£110 |
Power 3 Medical Products Inc -Financial Company Report
|
February 2008 |
£110 |
Power Medical Interventions, Inc. -Financial Company Report
|
February 2008 |
£110 |
Prescient NeuroPharma Inc -Financial Company Report
|
February 2008 |
£110 |
Pressure BioSciences Inc -Financial Company Report
|
February 2008 |
£110 |
Pro -Dex Inc -Financial Company Report
|
February 2008 |
£110 |
Premier Laser Systems Inc. -Financial Company Report
|
February 2008 |
£110 |
Precision Optics Corporation Inc -Financial Company Report
|
February 2008 |
£110 |
Prana Biotechnology Ltd -Financial Company Report
|
February 2008 |
£110 |
PreMD Inc -Financial Company Report
|
February 2008 |
£110 |
Plastic Surgery Co., The -Financial Company Report
|
February 2008 |
£110 |
Pipex Pharmaceuticals, Inc. -Financial Company Report
|
February 2008 |
£110 |
Pharmaxis Ltd. -Financial Company Report
|
February 2008 |
£110 |
Pharming Group N.V. -Financial Company Report
|
February 2008 |
£110 |
Pharmion Corp -Financial Company Report
|
February 2008 |
£110 |
Pharmacyclics Inc -Financial Company Report
|
February 2008 |
£110 |
Pharmacopeia, Inc. -Financial Company Report
|
February 2008 |
£110 |
PharmaNet Development Group, Inc. -Financial Company Report
|
February 2008 |
£110 |
Pharmaceutical Product Development Inc -Financial Company Report
|
February 2008 |
£110 |
Pharmos Corporation -Financial Company Report
|
February 2008 |
£110 |
Pharsight Corporation -Financial Company Report
|
February 2008 |
£110 |
PhytoMedical Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Phytopharm PLC -Financial Company Report
|
February 2008 |
£110 |
Pilot Therapeutics Holdings Inc -Financial Company Report
|
February 2008 |
£110 |
Photon Technology International Inc -Financial Company Report
|
February 2008 |
£110 |
Photoelectron Corp. -Financial Company Report
|
February 2008 |
£110 |
Phase Forward Inc -Financial Company Report
|
February 2008 |
£110 |
PhotoMedex Inc -Financial Company Report
|
February 2008 |
£110 |
Merit Medical Systems Inc -Financial Company Report
|
February 2008 |
£110 |
Merge Healthcare -Financial Company Report
|
February 2008 |
£110 |
Huifeng Bio -Pharmaceutical Technology, Inc. -Financial Company Report
|
February 2008 |
£110 |
Human BioSystems. -Financial Company Report
|
February 2008 |
£110 |
Human Genome Sciences Inc -Financial Company Report
|
February 2008 |
£110 |
Hospira Inc -Financial Company Report
|
February 2008 |
£110 |
Hooper Holmes Inc -Financial Company Report
|
February 2008 |
£110 |
Hologic Inc -Financial Company Report
|
February 2008 |
£110 |
Home Diagnostics, Inc. -Financial Company Report
|
February 2008 |
£110 |
Honeywell International Inc. -Financial Company Report
|
February 2008 |
£110 |
Humana Inc -Financial Company Report
|
February 2008 |
£110 |
Hydromer Inc -Financial Company Report
|
February 2008 |
£110 |
IBSG International Inc -Financial Company Report
|
February 2008 |
£110 |
ICAgen Inc -Financial Company Report
|
February 2008 |
£110 |
ICON Plc -Financial Company Report
|
February 2008 |
£110 |
I -Flow Corporation -Financial Company Report
|
February 2008 |
£110 |
Hythiam Inc -Financial Company Report
|
February 2008 |
£110 |
Hydron Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Hypertension Diagnostics Inc -Financial Company Report
|
February 2008 |
£110 |
Holmes Biopharma, Inc. -Financial Company Report
|
February 2008 |
£110 |
Hollis -Eden Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Helix BioMedix Inc -Financial Company Report
|
February 2008 |
£110 |
Help at Home Inc -Financial Company Report
|
February 2008 |
£110 |
HemaCare Corporation -Financial Company Report
|
February 2008 |
£110 |
Helicos BioSciences Corporation -Financial Company Report
|
February 2008 |
£110 |
Healthways Inc -Financial Company Report
|
February 2008 |
£110 |
Healtheuniverse Inc. -Financial Company Report
|
February 2008 |
£110 |
Healthextras Inc. -Financial Company Report
|
February 2008 |
£110 |
Hemagen Diagnostics Inc -Financial Company Report
|
February 2008 |
£110 |
Hemispherx Biopharma Inc -Financial Company Report
|
February 2008 |
£110 |
Heska Corporation -Financial Company Report
|
February 2008 |
£110 |
Hi -Tech Pharmacal Co Inc -Financial Company Report
|
February 2008 |
£110 |
Hillenbrand Industries Inc -Financial Company Report
|
February 2008 |
£110 |
Hercules Incorporated -Financial Company Report
|
February 2008 |
£110 |
HepaLife Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Hemobiotech Inc -Financial Company Report
|
February 2008 |
£110 |
Henry Schein Inc -Financial Company Report
|
February 2008 |
£110 |
ICU Medical Inc -Financial Company Report
|
February 2008 |
£110 |
IDEXX Laboratories Inc -Financial Company Report
|
February 2008 |
£110 |
Immunicon Corp -Financial Company Report
|
February 2008 |
£110 |
ImmunoGen Inc -Financial Company Report
|
February 2008 |
£110 |
Immunomedics Inc -Financial Company Report
|
February 2008 |
£110 |
Immune Network Ltd. -Financial Company Report
|
February 2008 |
£110 |
ImmuCell Corporation -Financial Company Report
|
February 2008 |
£110 |
Imclone Systems Inc -Financial Company Report
|
February 2008 |
£110 |
Immtech Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Impax Laboratories Inc -Financial Company Report
|
February 2008 |
£110 |
Implant Sciences Corporation -Financial Company Report
|
February 2008 |
£110 |
Indevus Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Infinity Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Inflazyme Pharmaceuticals Ltd. -Financial Company Report
|
February 2008 |
£110 |
Incyte Corporation -Financial Company Report
|
February 2008 |
£110 |
InSite Vision Incorporated -Financial Company Report
|
February 2008 |
£110 |
InMedica Development Corp. -Financial Company Report
|
February 2008 |
£110 |
InNexus Biotechnology Inc -Financial Company Report
|
February 2008 |
£110 |
Imarx Therapeutics, Inc. -Financial Company Report
|
February 2008 |
£110 |
Imaging Diagnostic Systems Inc -Financial Company Report
|
February 2008 |
£110 |
IMCOR Pharmaceutical Co. -Financial Company Report
|
February 2008 |
£110 |
IMS Health Inc -Financial Company Report
|
February 2008 |
£110 |
IR Biosciences Holdings Inc -Financial Company Report
|
February 2008 |
£110 |
II -VI Inc -Financial Company Report
|
February 2008 |
£110 |
IGI Inc -Financial Company Report
|
February 2008 |
£110 |
IDM Pharma Inc -Financial Company Report
|
February 2008 |
£110 |
IGENE Biotechnology Inc. -Financial Company Report
|
February 2008 |
£110 |
IRIDEX Corp -Financial Company Report
|
February 2008 |
£110 |
IRIS International Inc -Financial Company Report
|
February 2008 |
£110 |
Idera Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Illumina Inc -Financial Company Report
|
February 2008 |
£110 |
Imagenetix Inc -Financial Company Report
|
February 2008 |
£110 |
Idenix Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
IVMD (UK) Ltd -Financial Company Report
|
February 2008 |
£110 |
ISTA Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
IVAX Diagnostics Inc -Financial Company Report
|
February 2008 |
£110 |
Healthcare Services Group Inc -Financial Company Report
|
February 2008 |
£110 |
Healthcare Integrated Services Inc. -Financial Company Report
|
February 2008 |
£110 |
GammaCan International Inc -Financial Company Report
|
February 2008 |
£110 |
Gedeon Richter Ltd -Financial Company Report
|
February 2008 |
£110 |
GelStat Corp -Financial Company Report
|
February 2008 |
£110 |
GW Pharmaceuticals PLC -Financial Company Report
|
February 2008 |
£110 |
GTX INC -Financial Company Report
|
February 2008 |
£110 |
Fresenius Medical Care Aktiengesellschaft -Financial Company Report
|
February 2008 |
£110 |
GPC Biotech AG -Financial Company Report
|
February 2008 |
£110 |
GTC Biotherapeutics Inc -Financial Company Report
|
February 2008 |
£110 |
Gen -Probe Incorporated -Financial Company Report
|
February 2008 |
£110 |
GenVec Inc -Financial Company Report
|
February 2008 |
£110 |
Genetic Technologies Ltd -Financial Company Report
|
February 2008 |
£110 |
Genetic Vectors, Inc. -Financial Company Report
|
February 2008 |
£110 |
Genitope Corp -Financial Company Report
|
February 2008 |
£110 |
Generex Biotechnology Corporation -Financial Company Report
|
February 2008 |
£110 |
Genelabs Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Genaera Corporation -Financial Company Report
|
February 2008 |
£110 |
GeneLink Inc -Financial Company Report
|
February 2008 |
£110 |
Forticell Bioscience, Inc. -Financial Company Report
|
February 2008 |
£110 |
Forest Laboratories Inc -Financial Company Report
|
February 2008 |
£110 |
Amicus Therapeutics, Inc. -Financial Company Report
|
February 2008 |
£110 |
Ardea Biosciences, Inc. -Financial Company Report
|
February 2008 |
£110 |
Arrhythmia Research Technology Inc -Financial Company Report
|
February 2008 |
£110 |
Allscripts Healthcare Solutions Inc -Financial Company Report
|
February 2008 |
£110 |
AHPC Holdings Inc -Financial Company Report
|
February 2008 |
£110 |
3M Co. -Financial Company Report
|
February 2008 |
£110 |
3SBio Inc. -Financial Company Report
|
February 2008 |
£110 |
Bayer Schering Pharma AG -Financial Company Report
|
February 2008 |
£110 |
Callisto Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Favrille Inc -Financial Company Report
|
February 2008 |
£110 |
Five Star Quality Care Inc -Financial Company Report
|
February 2008 |
£110 |
Forbes Medi -Tech Inc -Financial Company Report
|
February 2008 |
£110 |
FONAR Corporation -Financial Company Report
|
February 2008 |
£110 |
Eli Lilly & Co -Financial Company Report
|
February 2008 |
£110 |
Cytomedix Inc -Financial Company Report
|
February 2008 |
£110 |
Dr Reddys Laboratories Ltd -Financial Company Report
|
February 2008 |
£110 |
GenoMed Inc -Financial Company Report
|
February 2008 |
£110 |
Genomic Health Inc -Financial Company Report
|
February 2008 |
£110 |
Harvard Bioscience Inc -Financial Company Report
|
February 2008 |
£110 |
Hawkins Inc -Financial Company Report
|
February 2008 |
£110 |
Health Discovery Corp -Financial Company Report
|
February 2008 |
£110 |
Hansen Medical, Inc. -Financial Company Report
|
February 2008 |
£110 |
Hanger Orthopedic Group Inc -Financial Company Report
|
February 2008 |
£110 |
Halozyme Therapeutics Inc -Financial Company Report
|
February 2008 |
£110 |
Hana Biosciences Inc -Financial Company Report
|
February 2008 |
£110 |
Health Fitness Corporation -Financial Company Report
|
February 2008 |
£110 |
Health Management Associates Inc -Financial Company Report
|
February 2008 |
£110 |
HealthSport, Inc. -Financial Company Report
|
February 2008 |
£110 |
HealthSpring Inc. -Financial Company Report
|
February 2008 |
£110 |
HealthTronics Inc -Financial Company Report
|
February 2008 |
£110 |
HealthSouth Corporation -Financial Company Report
|
February 2008 |
£110 |
HealthRenu Medical Inc -Financial Company Report
|
February 2008 |
£110 |
Health Sciences Group Inc -Financial Company Report
|
February 2008 |
£110 |
HealthGate Data Corporation -Financial Company Report
|
February 2008 |
£110 |
Haemonetics Corporation -Financial Company Report
|
February 2008 |
£110 |
HMS Holdings Corp -Financial Company Report
|
February 2008 |
£110 |
GeoPharma Inc -Financial Company Report
|
February 2008 |
£110 |
GeoVax Labs Inc -Financial Company Report
|
February 2008 |
£110 |
Georgia Gulf Corporation -Financial Company Report
|
February 2008 |
£110 |
Genzyme Corporation -Financial Company Report
|
February 2008 |
£110 |
Gentiva Health Services Inc -Financial Company Report
|
February 2008 |
£110 |
Genta Incorporated -Financial Company Report
|
February 2008 |
£110 |
Gentium S.p.A -Financial Company Report
|
February 2008 |
£110 |
Gilead Sciences Inc -Financial Company Report
|
February 2008 |
£110 |
Given Imaging Ltd -Financial Company Report
|
February 2008 |
£110 |
H B Fuller Company -Financial Company Report
|
February 2008 |
£110 |
H.Lundbeck AS -Financial Company Report
|
February 2008 |
£110 |
HLTH Corp. -Financial Company Report
|
February 2008 |
£110 |
Greatbatch Inc -Financial Company Report
|
February 2008 |
£110 |
Grant Life Sciences Inc -Financial Company Report
|
February 2008 |
£110 |
GlaxoSmithKline plc -Financial Company Report
|
February 2008 |
£110 |
Graham -Field Health Products Inc -Financial Company Report
|
February 2008 |
£110 |
Infu -Tech Inc -Financial Company Report
|
February 2008 |
£110 |
Inhibitex Inc -Financial Company Report
|
February 2008 |
£110 |
MZT Holdings, Inc. -Financial Company Report
|
February 2008 |
£110 |
MacroChem Corporation -Financial Company Report
|
February 2008 |
£110 |
Magellan Health Services Inc -Financial Company Report
|
February 2008 |
£110 |
MTS Medication Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
MOCON Inc -Financial Company Report
|
February 2008 |
£110 |
MDS Inc -Financial Company Report
|
February 2008 |
£110 |
MGI Pharma Inc -Financial Company Report
|
February 2008 |
£110 |
MIV Therapeutics Inc -Financial Company Report
|
February 2008 |
£110 |
Magna -Lab Inc -Financial Company Report
|
February 2008 |
£110 |
Mammatech Corp -Financial Company Report
|
February 2008 |
£110 |
Martek Biosciences Corp -Financial Company Report
|
February 2008 |
£110 |
Martin Nutraceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Masimo Corporation -Financial Company Report
|
February 2008 |
£110 |
Marshall Edwards Inc -Financial Company Report
|
February 2008 |
£110 |
Mannatech Inc -Financial Company Report
|
February 2008 |
£110 |
Manhattan Pharmaceuticals Inc. -Financial Company Report
|
February 2008 |
£110 |
MannKind Corp -Financial Company Report
|
February 2008 |
£110 |
Luminex Corporation -Financial Company Report
|
February 2008 |
£110 |
Lumera Corp -Financial Company Report
|
February 2008 |
£110 |
Lifevantage Corporation -Financial Company Report
|
February 2008 |
£110 |
Ligand Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Lincare Holdings Inc -Financial Company Report
|
February 2008 |
£110 |
Lifesmart Nutrition Technologies Inc. -Financial Company Report
|
February 2008 |
£110 |
Lifepoint Inc. -Financial Company Report
|
February 2008 |
£110 |
Lifecore Biomedical Inc -Financial Company Report
|
February 2008 |
£110 |
Lifepoint Hospitals Inc -Financial Company Report
|
February 2008 |
£110 |
Linkwell Corp. -Financial Company Report
|
February 2008 |
£110 |
Lipid Sciences Inc -Financial Company Report
|
February 2008 |
£110 |
Lotus Pharmaceuticals, Inc. -Financial Company Report
|
February 2008 |
£110 |
Lpath Inc -Financial Company Report
|
February 2008 |
£110 |
Lubrizol Corporation -Financial Company Report
|
February 2008 |
£110 |
Lorus Therapeutics Inc -Financial Company Report
|
February 2008 |
£110 |
Longs Drug Stores Corp -Financial Company Report
|
February 2008 |
£110 |
Lixte Biotechnology Holdings, Inc. -Financial Company Report
|
February 2008 |
£110 |
Longport Inc -Financial Company Report
|
February 2008 |
£110 |
Matria Healthcare Inc -Financial Company Report
|
February 2008 |
£110 |
Matrixx Initiatives Inc -Financial Company Report
|
February 2008 |
£110 |
Medivation Inc -Financial Company Report
|
February 2008 |
£110 |
Mediware Information Systems Inc -Financial Company Report
|
February 2008 |
£110 |
Medizone International Inc -Financial Company Report
|
February 2008 |
£110 |
Medisys Technologies, Inc -Financial Company Report
|
February 2008 |
£110 |
Mediscience Technology Corp -Financial Company Report
|
February 2008 |
£110 |
Medicure Inc -Financial Company Report
|
February 2008 |
£110 |
Medifast Inc -Financial Company Report
|
February 2008 |
£110 |
Medjet Inc -Financial Company Report
|
February 2008 |
£110 |
Medtox Scientific Inc -Financial Company Report
|
February 2008 |
£110 |
Mentor Corporation -Financial Company Report
|
February 2008 |
£110 |
Mera Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Merck & Co Inc -Financial Company Report
|
February 2008 |
£110 |
Memory Pharmaceuticals Corp -Financial Company Report
|
February 2008 |
£110 |
Meldex International Plc -Financial Company Report
|
February 2008 |
£110 |
Medtronic Inc -Financial Company Report
|
February 2008 |
£110 |
Medwave Inc -Financial Company Report
|
February 2008 |
£110 |
Medicis Pharmaceutical Corp -Financial Company Report
|
February 2008 |
£110 |
MediciNova Inc -Financial Company Report
|
February 2008 |
£110 |
MedQuist Inc -Financial Company Report
|
February 2008 |
£110 |
MedSearch, Inc. -Financial Company Report
|
February 2008 |
£110 |
MedaSorb Technologies Corp -Financial Company Report
|
February 2008 |
£110 |
MedMira Inc -Financial Company Report
|
February 2008 |
£110 |
Med Gen Inc -Financial Company Report
|
February 2008 |
£110 |
Maxygen Inc -Financial Company Report
|
February 2008 |
£110 |
McKesson Corporation -Financial Company Report
|
February 2008 |
£110 |
Medarex Inc -Financial Company Report
|
February 2008 |
£110 |
Medcath Corp -Financial Company Report
|
February 2008 |
£110 |
Medical Nutrition USA Inc -Financial Company Report
|
February 2008 |
£110 |
Medical Resources Inc -Financial Company Report
|
February 2008 |
£110 |
MedicalCV Inc -Financial Company Report
|
February 2008 |
£110 |
Medical Action Industries Inc -Financial Company Report
|
February 2008 |
£110 |
MedicSight Inc New -Financial Company Report
|
February 2008 |
£110 |
MediCor Ltd -Financial Company Report
|
February 2008 |
£110 |
MediStem Laboratories, Inc. -Financial Company Report
|
February 2008 |
£110 |
LifeQuest World Corporation -Financial Company Report
|
February 2008 |
£110 |
LifeCell Corporation -Financial Company Report
|
February 2008 |
£110 |
Invitro International -Financial Company Report
|
February 2008 |
£110 |
Invitrogen Corporation -Financial Company Report
|
February 2008 |
£110 |
Inyx Inc -Financial Company Report
|
February 2008 |
£110 |
Inverness Medical Innovations Inc -Financial Company Report
|
February 2008 |
£110 |
Invacare Corporation -Financial Company Report
|
February 2008 |
£110 |
Introgen Therapeutics Inc -Financial Company Report
|
February 2008 |
£110 |
Intuitive Surgical Inc -Financial Company Report
|
February 2008 |
£110 |
Iomai Corp -Financial Company Report
|
February 2008 |
£110 |
Isis Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Javelin Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Jazz Pharmaceuticals, Inc. -Financial Company Report
|
February 2008 |
£110 |
Johnson & Johnson -Financial Company Report
|
February 2008 |
£110 |
JMAR Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
J Rish Group Inc -Financial Company Report
|
February 2008 |
£110 |
IsoRay Inc -Financial Company Report
|
February 2008 |
£110 |
Isolagen Inc -Financial Company Report
|
February 2008 |
£110 |
Interpharm Holdings Inc -Financial Company Report
|
February 2008 |
£110 |
International Stem Cell Corporation -Financial Company Report
|
February 2008 |
£110 |
Inspire Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Insulet Corporation -Financial Company Report
|
February 2008 |
£110 |
Integra LifeSciences Holdings Corp -Financial Company Report
|
February 2008 |
£110 |
Insmed Incorporated -Financial Company Report
|
February 2008 |
£110 |
Inovio Biomedical Corp -Financial Company Report
|
February 2008 |
£110 |
Innovative Clinical Solutions Ltd. -Financial Company Report
|
February 2008 |
£110 |
Innovive Pharmaceuticals, Inc. -Financial Company Report
|
February 2008 |
£110 |
IntegraMed America Inc -Financial Company Report
|
February 2008 |
£110 |
Integrated BioPharma Inc -Financial Company Report
|
February 2008 |
£110 |
InterMune Inc -Financial Company Report
|
February 2008 |
£110 |
Interleukin Genetics Inc -Financial Company Report
|
February 2008 |
£110 |
International Isotopes Inc -Financial Company Report
|
February 2008 |
£110 |
Intellect Neurosciences, Inc. -Financial Company Report
|
February 2008 |
£110 |
IntelGenx Technologies Corp. -Financial Company Report
|
February 2008 |
£110 |
Integrated Pharmaceuticals, Inc. -Financial Company Report
|
February 2008 |
£110 |
Integrated Surgical Systems Inc -Financial Company Report
|
February 2008 |
£110 |
Juniper Group Inc. -Financial Company Report
|
February 2008 |
£110 |
KMG Chemicals Inc -Financial Company Report
|
February 2008 |
£110 |
Large Scale Biology Corporation -Financial Company Report
|
February 2008 |
£110 |
LaserSight Incorporated -Financial Company Report
|
February 2008 |
£110 |
LeMaitre Vascular, Inc. -Financial Company Report
|
February 2008 |
£110 |
Lannett Co Inc -Financial Company Report
|
February 2008 |
£110 |
Langer Inc -Financial Company Report
|
February 2008 |
£110 |
Laboratory Corp Of America Holdings -Financial Company Report
|
February 2008 |
£110 |
Lancer Orthodontics Inc -Financial Company Report
|
February 2008 |
£110 |
LecTec Corp -Financial Company Report
|
February 2008 |
£110 |
Lee Pharmaceuticals -Financial Company Report
|
February 2008 |
£110 |
Lexington Healthcare Group Inc -Financial Company Report
|
February 2008 |
£110 |
Life Sciences Research Inc. -Financial Company Report
|
February 2008 |
£110 |
Life Therapeutics Ltd -Financial Company Report
|
February 2008 |
£110 |
Lexicon Pharmaceuticals, Inc -Financial Company Report
|
February 2008 |
£110 |
Lev Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Lescarden Inc -Financial Company Report
|
February 2008 |
£110 |
Let's Talk Recovery Inc -Financial Company Report
|
February 2008 |
£110 |
La Jolla Pharmaceutical Co -Financial Company Report
|
February 2008 |
£110 |
LSB INDUSTRIES INC -Financial Company Report
|
February 2008 |
£110 |
Keryx Biopharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Kimberly -Clark Corp. -Financial Company Report
|
February 2008 |
£110 |
Kindred Healthcare Inc -Financial Company Report
|
February 2008 |
£110 |
Kent International Holdings Inc -Financial Company Report
|
February 2008 |
£110 |
Kensey Nash Corporation -Financial Company Report
|
February 2008 |
£110 |
KV Pharmaceutical Co. -Financial Company Report
|
February 2008 |
£110 |
Kendle International Inc -Financial Company Report
|
February 2008 |
£110 |
Kinetic Concepts Inc -Financial Company Report
|
February 2008 |
£110 |
King Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
LCA -Vision Inc -Financial Company Report
|
February 2008 |
£110 |
LHC Group, Inc. -Financial Company Report
|
February 2008 |
£110 |
LMS Medical Systems Inc. -Financial Company Report
|
February 2008 |
£110 |
LAM Pharmaceutical Corp -Financial Company Report
|
February 2008 |
£110 |
Kyto BioPharma Inc -Financial Company Report
|
February 2008 |
£110 |
Kosan Biosciences Incorporated -Financial Company Report
|
February 2008 |
£110 |
Kuala Healthcare Inc -Financial Company Report
|
February 2008 |
£110 |
Rotech Healthcare Inc -Financial Company Report
|
February 2008 |
£110 |
Rural -Financial Company Report
|
February 2008 |
£110 |
Biotech Holdings Ltd -Financial Company Report
|
February 2008 |
£110 |
Birner Dental Management Services Inc -Financial Company Report
|
February 2008 |
£110 |
Boston Scientific Corporation -Financial Company Report
|
February 2008 |
£110 |
Biosyntech Inc -Financial Company Report
|
February 2008 |
£110 |
Biosynergy Inc -Financial Company Report
|
February 2008 |
£110 |
Biophage Pharma Inc -Financial Company Report
|
February 2008 |
£110 |
Biophan Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Biopure Corporation -Financial Company Report
|
February 2008 |
£110 |
Bradley Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Brainstorm Cell Therapeutics Inc -Financial Company Report
|
February 2008 |
£110 |
Immucor Inc -Financial Company Report
|
February 2008 |
£110 |
Natural Health Trends Corp. -Financial Company Report
|
February 2008 |
£110 |
Natus Medical Incorporated -Financial Company Report
|
February 2008 |
£110 |
Diametrics Medical Inc -Financial Company Report
|
February 2008 |
£110 |
CR Bard Inc. -Financial Company Report
|
February 2008 |
£110 |
Bristol -Myers Squibb Company -Financial Company Report
|
February 2008 |
£110 |
Bruker BioSciences Corporation -Financial Company Report
|
February 2008 |
£110 |
Bionovo Inc -Financial Company Report
|
February 2008 |
£110 |
Bioniche Life Sciences Inc -Financial Company Report
|
February 2008 |
£110 |
BioSphere Medical Inc -Financial Company Report
|
February 2008 |
£110 |
BioSyent Inc -Financial Company Report
|
February 2008 |
£110 |
BioTech Medics, Inc. -Financial Company Report
|
February 2008 |
£110 |
BioSpecifics Technologies Corp -Financial Company Report
|
February 2008 |
£110 |
BioScrip Inc -Financial Company Report
|
February 2008 |
£110 |
BioMimetic Therapeutics Inc -Financial Company Report
|
February 2008 |
£110 |
BioSante Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
BioTime Inc -Financial Company Report
|
February 2008 |
£110 |
Bioanalytical Systems Inc -Financial Company Report
|
February 2008 |
£110 |
Bioject Medical Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Biomerica Inc -Financial Company Report
|
February 2008 |
£110 |
Biomoda Inc -Financial Company Report
|
February 2008 |
£110 |
Biogen Idec Inc -Financial Company Report
|
February 2008 |
£110 |
Biodel Inc. -Financial Company Report
|
February 2008 |
£110 |
Biocon Ltd -Financial Company Report
|
February 2008 |
£110 |
Biocoral Inc -Financial Company Report
|
February 2008 |
£110 |
New York Health Care Inc -Financial Company Report
|
February 2008 |
£110 |
World Health Energy, Inc. -Financial Company Report
|
February 2008 |
£110 |
Cambrex Corporation -Financial Company Report
|
February 2008 |
£110 |
Cambridge Heart Inc -Financial Company Report
|
February 2008 |
£110 |
Candela Corporation -Financial Company Report
|
February 2008 |
£110 |
Calypte Biomedical Corporation -Financial Company Report
|
February 2008 |
£110 |
Caliper Life Sciences Inc -Financial Company Report
|
February 2008 |
£110 |
Cadence Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
CalbaTech Inc -Financial Company Report
|
February 2008 |
£110 |
Cantel Medical Corporation -Financial Company Report
|
February 2008 |
£110 |
Capital Senior Living Corporation -Financial Company Report
|
February 2008 |
£110 |
Cardima Inc -Financial Company Report
|
February 2008 |
£110 |
Cardinal Health Inc -Financial Company Report
|
February 2008 |
£110 |
CardioDynamics International Corp -Financial Company Report
|
February 2008 |
£110 |
Cardica Inc -Financial Company Report
|
February 2008 |
£110 |
Cardiac Science Corp -Financial Company Report
|
February 2008 |
£110 |
Caprius Inc -Financial Company Report
|
February 2008 |
£110 |
Caraco Pharmaceutical Laboratories Ltd -Financial Company Report
|
February 2008 |
£110 |
Cabot Corporation -Financial Company Report
|
February 2008 |
£110 |
CYTOGEN Corporation -Financial Company Report
|
February 2008 |
£110 |
Biovail Corporation -Financial Company Report
|
February 2008 |
£110 |
Biovest International Inc. -Financial Company Report
|
February 2008 |
£110 |
Bovie Medical Corp -Financial Company Report
|
February 2008 |
£110 |
Biofield Corp -Financial Company Report
|
February 2008 |
£110 |
Bavarian Nordic AS -Financial Company Report
|
February 2008 |
£110 |
4 -D Neuroimaging -Financial Company Report
|
February 2008 |
£110 |
Advanced Medical Optics Inc -Financial Company Report
|
February 2008 |
£110 |
CAS Medical Systems Inc -Financial Company Report
|
February 2008 |
£110 |
CDex, Inc. -Financial Company Report
|
February 2008 |
£110 |
CRYO -CELL International Inc -Financial Company Report
|
February 2008 |
£110 |
CV Therapeutics Inc -Financial Company Report
|
February 2008 |
£110 |
CVS Caremark Corp. -Financial Company Report
|
February 2008 |
£110 |
CPC Of America Inc -Financial Company Report
|
February 2008 |
£110 |
CONMED Corporation -Financial Company Report
|
February 2008 |
£110 |
CEL -SCI Corporation -Financial Company Report
|
February 2008 |
£110 |
CIGNA Corp. -Financial Company Report
|
February 2008 |
£110 |
BioMarin Pharmaceutical Inc -Financial Company Report
|
February 2008 |
£110 |
BioLife Solutions Inc -Financial Company Report
|
February 2008 |
£110 |
AstraZeneca Plc -Financial Company Report
|
February 2008 |
£110 |
Astralis Ltd -Financial Company Report
|
February 2008 |
£110 |
Astro -Med Inc -Financial Company Report
|
February 2008 |
£110 |
Astellas Pharma Inc -Financial Company Report
|
February 2008 |
£110 |
Aspyra Inc -Financial Company Report
|
February 2008 |
£110 |
Ashland Inc -Financial Company Report
|
February 2008 |
£110 |
Aspect Medical Systems Inc -Financial Company Report
|
February 2008 |
£110 |
AspenBio Pharma Inc -Financial Company Report
|
February 2008 |
£110 |
AtheroGenics Inc -Financial Company Report
|
February 2008 |
£110 |
Athersys, Inc. -Financial Company Report
|
February 2008 |
£110 |
Auxilium Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Avalon Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Avantogen Oncology, Inc. -Financial Company Report
|
February 2008 |
£110 |
AutoImmune Inc -Financial Company Report
|
February 2008 |
£110 |
Auriga Laboratories Inc. -Financial Company Report
|
February 2008 |
£110 |
AtriCure Inc -Financial Company Report
|
February 2008 |
£110 |
Atrion Corporation -Financial Company Report
|
February 2008 |
£110 |
ArthroCare Corporation -Financial Company Report
|
February 2008 |
£110 |
Artes Medical, Inc. -Financial Company Report
|
February 2008 |
£110 |
Applied NeuroSolutions Inc -Financial Company Report
|
February 2008 |
£110 |
Apria Healthcare Group Inc -Financial Company Report
|
February 2008 |
£110 |
ArQule Inc -Financial Company Report
|
February 2008 |
£110 |
Applera Corp -Applied Biosystems Group -Financial Company Report
|
February 2008 |
£110 |
Apogee Technology Inc -Financial Company Report
|
February 2008 |
£110 |
Antigenics Inc -Financial Company Report
|
February 2008 |
£110 |
Antisoma PLC -Financial Company Report
|
February 2008 |
£110 |
Aradigm Corp -Financial Company Report
|
February 2008 |
£110 |
Arana Therapeutics Limited -Financial Company Report
|
February 2008 |
£110 |
Aristotle Corporation -Financial Company Report
|
February 2008 |
£110 |
Array BioPharma Inc -Financial Company Report
|
February 2008 |
£110 |
Arrowhead Research Corp. -Financial Company Report
|
February 2008 |
£110 |
Ariad Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Arena Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Arbios Systems Inc -Financial Company Report
|
February 2008 |
£110 |
Arch Chemicals Inc -Financial Company Report
|
February 2008 |
£110 |
Averion International Corp. -Financial Company Report
|
February 2008 |
£110 |
Avicena Group Inc -Financial Company Report
|
February 2008 |
£110 |
Bio -Bridge Science Inc -Financial Company Report
|
February 2008 |
£110 |
Bio -Imaging Technologies Inc -Financial Company Report
|
February 2008 |
£110 |
Bio -Matrix Scientific Group, Inc. -Financial Company Report
|
February 2008 |
£110 |
Bentley Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Benitec Ltd -Financial Company Report
|
February 2008 |
£110 |
Beijing Med -Pharm Corp. -Financial Company Report
|
February 2008 |
£110 |
Benda Pharmaceutical, Inc -Financial Company Report
|
February 2008 |
£110 |
Bio -Rad Laboratories Inc. -Financial Company Report
|
February 2008 |
£110 |
Bio -Reference Laboratories Inc -Financial Company Report
|
February 2008 |
£110 |
BioForce Nanosciences Holdings Inc -Financial Company Report
|
February 2008 |
£110 |
BioForm Medical, Inc. -Financial Company Report
|
February 2008 |
£110 |
BioLase Technology Inc -Financial Company Report
|
February 2008 |
£110 |
BioElectronics Corporation -Financial Company Report
|
February 2008 |
£110 |
BioDelivery Sciences International Inc -Financial Company Report
|
February 2008 |
£110 |
BioCryst Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
BioCurex Inc -Financial Company Report
|
February 2008 |
£110 |
Becton Dickinson and Company -Financial Company Report
|
February 2008 |
£110 |
Beckman Coulter Inc -Financial Company Report
|
February 2008 |
£110 |
BIOQUAL Inc -Financial Company Report
|
February 2008 |
£110 |
BSD Medical Corp -Financial Company Report
|
February 2008 |
£110 |
BSML, Inc. -Financial Company Report
|
February 2008 |
£110 |
BASF AG -Financial Company Report
|
February 2008 |
£110 |
Axcan Pharma Inc -Financial Company Report
|
February 2008 |
£110 |
Avigen Inc -Financial Company Report
|
February 2008 |
£110 |
Avitar Inc -Financial Company Report
|
February 2008 |
£110 |
Bactolac Pharmaceutical Inc. -Financial Company Report
|
February 2008 |
£110 |
Badger Meter Inc -Financial Company Report
|
February 2008 |
£110 |
Baxter International Inc -Financial Company Report
|
February 2008 |
£110 |
Bayer Ag -Financial Company Report
|
February 2008 |
£110 |
Baywood International Inc -Financial Company Report
|
February 2008 |
£110 |
Basilea Pharmaceutica AG -Financial Company Report
|
February 2008 |
£110 |
Barrier Therapeutics Inc -Financial Company Report
|
February 2008 |
£110 |
Balchem Corp -Financial Company Report
|
February 2008 |
£110 |
Barr Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
CardioGenesis Corporation -Financial Company Report
|
February 2008 |
£110 |
CardioTech International Inc -Financial Company Report
|
February 2008 |
£110 |
Cynosure, Inc. -Financial Company Report
|
February 2008 |
£110 |
Cyplasin Biomedical Ltd. -Financial Company Report
|
February 2008 |
£110 |
Cypress Bioscience Incorporated -Financial Company Report
|
February 2008 |
£110 |
Cyclacel Pharmaceuticals, Inc. -Financial Company Report
|
February 2008 |
£110 |
Cyberonics Inc -Financial Company Report
|
February 2008 |
£110 |
Cyanotech Corporation -Financial Company Report
|
February 2008 |
£110 |
CyberCare Inc -Financial Company Report
|
February 2008 |
£110 |
Cyberkinetics Neurotechnology Systems Inc -Financial Company Report
|
February 2008 |
£110 |
CytRx Corporation -Financial Company Report
|
February 2008 |
£110 |
Cytec Industries Inc -Financial Company Report
|
February 2008 |
£110 |
Cytori Therapeutics Inc -Financial Company Report
|
February 2008 |
£110 |
Cytos Biotechnology AG -Financial Company Report
|
February 2008 |
£110 |
DATATRAK International Inc -Financial Company Report
|
February 2008 |
£110 |
Cytokinetics Inc -Financial Company Report
|
February 2008 |
£110 |
Cytogenix Inc -Financial Company Report
|
February 2008 |
£110 |
CytoDyn Inc -Financial Company Report
|
February 2008 |
£110 |
Cytocore, Inc. -Financial Company Report
|
February 2008 |
£110 |
Cutera Inc -Financial Company Report
|
February 2008 |
£110 |
Curon Medical Inc -Financial Company Report
|
February 2008 |
£110 |
Covance Inc -Financial Company Report
|
February 2008 |
£110 |
Coventry Health Care Inc -Financial Company Report
|
February 2008 |
£110 |
Covidien, Ltd. -Financial Company Report
|
February 2008 |
£110 |
Cougar Biotechnology, Inc. -Financial Company Report
|
February 2008 |
£110 |
Cortex Pharmaceuticals Inc -Financial Company Report
|
February 2008 |
£110 |
Corgenix Medical Corporation -Financial Company Report
|
February 2008 |
£110 |
|
|
